<tei xml:space="preserve">
    <teiHeader>
        <fileDesc xml:id="_0"/>
    </teiHeader>
    <text xml:lang="en">
        <listBibl>

        REFERENCES<lb/> 
        <bibl><label>[1]</label><lb/> Beal, M.F.; Lang, A.E.; Ludolph, A.C. Neurodegenerative<lb/> Diseases: Neurobiology, Pathogenesis and Therapeutics.<lb/> Cambridge University Press: UK, 2005.<lb/> </bibl>
        <bibl><label>[2]</label><lb/> Bio Portfolio. New molecular target identified for the prevention of<lb/> Alzheimer&apos;s disease. http://www.bioportfolio.com/news/DailyUpda<lb/> tes_63.htm<lb/> </bibl>
        <bibl><label>[3]</label><lb/> Pepeu, G.; Giovannini, M.G. Cholinesterase inhibitors and beyond.<lb/> Curr. Alzheimer Res., 2009, 6, 86-96.<lb/> </bibl>
        <bibl><label>[4]</label><lb/> Schapira, A.H.; Emre, M.; Jenner, P.; Poewe, W. Levodopa in the<lb/> treatment of Parkinson&apos;s disease. Eur. J. Neurol., 2009, 16, 982-<lb/>989.<lb/> </bibl>
        <bibl><label>[5]</label><lb/> Glenner, G.G.; Wong, C.W. Alzheimer&apos;s disease: initial report of<lb/> the purification and characterization of a novel cerebrovascular<lb/> amyloid protein. Biochem. Biophys. Res. Commun., 1984, 120,<lb/> 885-890.<lb/> </bibl>
        <bibl><label>[6]</label><lb/> Masters, C.L.; Simms, G.; Weinman, N.A.; Multhaup, G.;<lb/> McDonald, B.L.; Beyreuther, K. Amyloid plaque core protein in<lb/> Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci.<lb/> USA, 1985a, 82, 4245-4249.<lb/> </bibl>
        <bibl><label>[7]</label><lb/> Masters, C.L.; Multhaup, G.; Simms, G.; Pottgiesser, J.; Martins,<lb/> R.N.; Beyreuther, K. Neuronal origin of a cerebral amyloid:<lb/> neurofibrillary tangles of Alzheimer&apos;s disease contain the same<lb/> protein as the amyloid of plaque cores and blood vessels. EMBO J.,<lb/> 1985b, 4, 2757-2763.<lb/> </bibl>
        <bibl><label>[8]</label><lb/> Tanzi, R.E.; McClatchey, A.I.; Lamperti, E.D.; Villa-Komaroff, L.;<lb/> Gusella, J.F.; Neve, R.L. Protease inhibitor domain encoded by an<lb/> amyloid protein precursor mRNA associated with Alzheimer&apos;s<lb/> disease. Nature, 1988, 331, 528-530.<lb/> </bibl>
        <bibl><label>[9]</label><lb/> Spillantini, M.G.; Schmidt, M.L.; Lee, V.M.; Trojanowski, J.Q.;<lb/> Jakes, R.; Goedert, M. Alpha-synuclein in Lewy bodies. Nature,<lb/> 1997, 388, 839-840.<lb/> </bibl>
        <bibl><label>[10]</label><lb/> Wolozin, B.L.; Pruchnicki, A.; Dickson, D.W.; Davies, P. A<lb/> neuronal antigen in the brains of Alzheimer patients. Science, 1986,<lb/> 232, 648-650.<lb/> </bibl>
        <bibl><label>[11]</label><lb/> Grundke-Iqbal, I.; Iqbal, K.; Quinlan, M.; Tung, Y.C.; Zaidi, M.S.;<lb/> Wisniewski, H.M. Microtubule-associated protein tau. A<lb/> component of Alzheimer paired helical filaments. J. Biol. Chem.,<lb/> 1986, 261, 6084-6089.<lb/> </bibl>
        <bibl><label>[12]</label><lb/> Wood, J.G.; Mirra, S.S.; Pollock, N.J.; Binder, L.I. Neurofibrillary<lb/> tangles of Alzheimer disease share antigenic determinants with the<lb/> axonal microtubule-associated protein tau (tau). Proc. Natl. Acad.<lb/> Sci. USA, 1986, 83, 4040-4043.<lb/> </bibl>
        <bibl><label>[13]</label><lb/> Kosik, K.S.; Joachim, C.L.; Selkoe, D.J. Microtubule-associated<lb/> protein tau (tau) is a major antigenic component of paired helical<lb/> filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA, 1986,<lb/> 83, 4044-4048.<lb/> </bibl>
        <bibl><label>[14]</label><lb/> Ihara, Y.; Nukina, N.; Miura, R.; Ogawara, M. Phosphorylated tau<lb/> protein is integrated into paired helical filaments in Alzheimer&apos;s<lb/> disease. J. Biochem., 1986, 99, 1807-1810.<lb/> </bibl>
        <bibl><label>[15]</label><lb/> Neumann, M.; Sampathu, D.M.; Kwong, L.K.; Truax, A.C.;<lb/> Micsenyi, M.C.; Chou, T.T.; Bruce, J.; Schuck, T.; Grossman, M.;<lb/> Clark, C.M.; McCluskey, L.F.; Miller, B.L.; Masliah, E.;<lb/> Mackenzie, I.R.; Feldman, H.; Feiden, W.; Kretzschmar, H.A.;<lb/> Trojanowski, J.Q.; Lee, V.M. Ubiquitinated TDP-43 in<lb/> frontotemporal lobar degeneration and amyotrophic lateral<lb/> sclerosis. Science, 2006, 314, 130-133.<lb/> </bibl>
        <bibl><label>[16]</label><lb/> Arai, T.; Hasegawa, M.; Akiyama, H.; Ikeda, K.; Nonaka, T.; Mori,<lb/> H.; Mann, D.; Tsuchiya, K.; Yoshida, M.; Hashizume, Y.; Oda, T.<lb/> TDP-43 is a component of ubiquitin-positive tau-negative<lb/> inclusions in frontotemporal lobar degeneration and amyotrophic<lb/> lateral sclerosis. Biochem. Biophys. Res. Commun., 2006, 351, 602-<lb/>611.<lb/> </bibl>
        <bibl><label>[17]</label><lb/> Satake, W.; Nakabayashi, Y.; Mizuta, I.; Hirota, Y.; Ito, C.; Kubo,<lb/> M.; Kawaguchi, T.; Tsunoda, T.; Watanabe, M.; Takeda, A.;<lb/> Tomiyama, H.; Nakashima, K.; Hasegawa, K.; Obata, F.;<lb/> Yoshikawa, T.; Kawakami, H.; Sakoda, S.; Yamamoto, M.;<lb/> Hattori, N.; Murata, M.; Nakamura, Y.; Toda, T. Genome-wide<lb/> association study identifies common variants at four loci as genetic<lb/> risk factors for Parkinson&apos;s disease. Nat. Genet., 2009, 41, 1303-<lb/>1307.<lb/> </bibl>
        <bibl><label>[18]</label><lb/> Simón-Sánchez, J.; Schulte, C.; Bras, J.M.; Sharma, M.; Gibbs,<lb/> J.R.; Berg, D.; Paisan-Ruiz, C.; Lichtner, P.; Scholz, S.W.;<lb/> Hernandez, D.G.; Krüger, R.; Federoff, M.; Klein, C.; Goate, A.;<lb/> Perlmutter, J.; Bonin, M.; Nalls, M.A.; Illig, T.; Gieger, C.;<lb/> Houlden, H.; Steffens, M.; Okun, M.S.; Racette, B.A.; Cookson,<lb/> M.R.; Foote, K.D.; Fernandez, H.H.; Traynor, B.J.; Schreiber, S.;<lb/> Arepalli, S.; Zonozi, R.; Gwinn, K.; van der Brug, M.; Lopez, G.;<lb/> Chanock, S.J.; Schatzkin, A.; Park, Y.; Hollenbeck, A.; Gao, J.;<lb/> Huang, X.; Wood, N.W.; Lorenz, D.; Deuschl, G.; Chen, H.; Riess,<lb/> O.; Hardy, J.A.; Singleton, A.B.; Gasser, T. Genome-wide<lb/> association study reveals genetic risk underlying Parkinson&apos;s<lb/> disease. Nat. Genet., 2009, 41, 1308-1312.<lb/> </bibl>
        <bibl><label>[19]</label><lb/> Winderickx, J.; Delay, C.; De Vos, A.; Klinger, H.; Pellens, K.;<lb/> Vanhelmont, T.; Van Leuven, F.; Zabrocki, P. Protein folding<lb/> diseases and neurodegeneration: lessons learned from yeast.<lb/> Biochim. Biophys. Acta, 2008, 1783, 1381-1395.<lb/> </bibl>
        <bibl><label>[20]</label><lb/> Teschendorf, D.; Link, C.D. What have worm models told us about<lb/> the mechanisms of neuronal dysfunction in human<lb/> neurodegenerative diseases? Mol. Neurodegener., 2009, 4, 38.<lb/> </bibl>
        <bibl><label>[21]</label><lb/> Adoutte, A.; Balavoine, G.; Lartillot, N.; Lespinet, O.;<lb/> Prud&apos;homme, B.; de Rosa, R. The new animal phylogeny:<lb/> Reliability and implications. Proc. Natl. Acad. Sci. USA, 2000, 97,<lb/> 4453-4465.<lb/> </bibl>
        <bibl><label>[22]</label><lb/> Peterson, K.J.; Lyons, J.B.; Nowak, K.S.; Takacs, C.M.; Wargo,<lb/> M.J.; McPeek, M.A. Estimating metazoan divergence times with a<lb/> molecular clock. Proc. Natl. Acad. Sci. USA, 2004, 101, 6536-<lb/>6541.<lb/> </bibl>
        <bibl><label>[23]</label><lb/> Sturtevant, A.E.; Lewis, E.B. A History of Genetics. Cold Spring<lb/> Harbor Laboratory Press: USA, 2001.<lb/> </bibl>
        <bibl><label>[24]</label><lb/> Piper, M.D.; Skorupa, D.; Partridge, L. Diet, metabolism and<lb/> lifespan in Drosophila. Exp. Gerontol., 2005, 40, 857-862.<lb/> </bibl>
        <bibl><label>[25]</label><lb/> Pletcher, SD.; Libert, S.; Skorupa, D. Flies and their golden apples:<lb/> the effect of dietary restriction on Drosophila aging and age-<lb/>dependent gene expression. Ageing Res. Rev., 2005, 4, 451-480.<lb/> </bibl>
        <bibl><label>[26]</label><lb/> McGuire, S.E.; Deshazer, M.; Davis, R.L. Thirty years of olfactory<lb/> learning and memory research in Drosophila melanogaster. Prog.<lb/> Neurobiol., 2005, 76, 328-347.<lb/> </bibl>
        <bibl><label>[27]</label><lb/> Margulies, C.; Tully, T.; Dubnau, J. Deconstructing memory in<lb/> Drosophila. Curr. Biol., 2005, 15, R700-R713.<lb/> </bibl>
        <bibl><label>[28]</label><lb/> Nichols,<lb/> C.D.<lb/> Drosophila<lb/> melanogaster<lb/> neurobiology,<lb/> neuropharmacology, and how the fly can inform central nervous<lb/> system drug discovery. Pharmacol. Ther., 2006, 112, 677-700.<lb/> </bibl>
        <bibl><label>[29]</label><lb/> Adams, M.D.; Celniker, S.E.; Holt, R.A.; Evans, C.A.; Gocayne,<lb/> J.D.; Amanatides, P.G.; Scherer, S.E.; Li, P.W.; Hoskins, R.A.;<lb/> Galle, R.F.; George, R.A.; Lewis, S.E.; Richards, S.; Ashburner,<lb/> M.; Henderson, S.N.; Sutton, G.G.; Wortman, J.R.; Yandell, M.D.;<lb/> Zhang, Q.; Chen, L.X.; Brandon, R.C.; Rogers, Y.H.; Blazej, R.G.;<lb/> Champe, M.; Pfeiffer, B.D.; Wan, K.H.; Doyle, C.; Baxter, E.G.;<lb/> Helt, G.; Nelson, C.R.; Gabor, G.L.; Abril, J.F.; Agbayani, A.; An,<lb/> H.J.; Andrews-Pfannkoch, C.; Baldwin, D.; Ballew, R.M.; Basu,<lb/> A.; Baxendale, J.; Bayraktaroglu, L.; Beasley, E.M.; Beeson, K.Y.;<lb/> Benos, P.V.; Berman, P.; Bhandari, D.; Bolshakov, S.; Borkova,<lb/> D.; Botchan, M.R.; Bouck, J.; Brokstein, P.; Brottier, P.; Burtis,<lb/> K.C.; Busam, D.A.; Butler, H.; Cadieu, E.; Center, A.; Chandra, I.;<lb/> Cherry, J.M.; Cawley, S.; Dahlke, C.; Davenport, L.B.; Davies, P.;<lb/> de Pablos, B.; Delcher, A.; Deng, Z.; Mays, A.D.; Dew, I.; Dietz,<lb/> S.M.; Dodson, K.; Doup, L.E.; Downes, M.; Dugan-Rocha, S.;<lb/> Dunkov, B.C.; Dunn, P.; Durbin, K.J.; Evangelista, C.C.; Ferraz,<lb/> C.; Ferriera, S.; Fleischmann, W.; Fosler, C.; Gabrielian, A.E.;<lb/> Garg, N.S.; Gelbart, W.M.; Glasser, K.; Glodek, A.; Gong, F.;<lb/> Gorrell, J.H.; Gu, Z.; Guan, P.; Harris, M.; Harris, N.L.; Harvey,<lb/> D.; Heiman, T.J.; Hernandez, J.R.; Houck, J.; Hostin, D.; Houston,<lb/> K.A.; Howland, T.J.; Wei, M.H.; Ibegwam, C.; Jalali, M.; Kalush,<lb/> F.; Karpen, G.H.; Ke, Z.; Kennison, J.A.; Ketchum, K.A.; Kimmel,<lb/> B.E.; Kodira, C.D.; Kraft, C.; Kravitz, S.; Kulp, D.; Lai, Z.; Lasko,<lb/> P.; Lei, Y.; Levitsky, A.A.; Li, J.; Li, Z.; Liang, Y.; Lin, X.; Liu,<lb/> X.; Mattei, B.; McIntosh, T.C.; McLeod, M.P.; McPherson, D.;<lb/> Merkulov, G.; Milshina, N.V.; Mobarry, C.; Morris, J.; Moshrefi,<lb/> A.; Mount, S.M.; Moy, M.; Murphy, B.; Murphy, L.; Muzny,<lb/> D.M.; Nelson, D.L.; Nelson, D.R.; Nelson, K.A.; Nixon, K.;<lb/> Nusskern, D.R.; Pacleb, JM.; Palazzolo, M.; Pittman, G.S.; Pan, S.;<lb/> Pollard, J.; Puri, V.; Reese, M.G.; Reinert, K.; Remington, K.,<lb/> Saunders, R.D.; Scheeler, F.; Shen, H.; Shue, B.C.; Sidén-Kiamos,<lb/> I.; Simpson, M.; Skupski, M.P.; Smith, T.; Spier, E.; Spradling,<lb/> A.C.; Stapleton, M.; Strong, R.; Sun, E.; Svirskas, R.; Tector, C.;<lb/> Turner, R.; Venter, E.; Wang, A.H.; Wang, X.; Wang, Z.Y.;<lb/> Wassarman, D.A.; Weinstock, G.M.; Weissenbach, J.; Williams,<lb/> S.M.; Woodage, T.; Worley, K.C.; Wu, D.; Yang, S.; Yao, Q.A.;<lb/> Ye, J.; Yeh, R.F.; Zaveri, J.S.; Zhan, M.; Zhang, G.; Zhao, Q.;<lb/> Zheng, L.; Zheng, X.H.; Zhong, F.N.; Zhong, W.; Zhou, X.; Zhu,<lb/> S.; Zhu, X.; Smith, H.O.; Gibbs, R.A.; Myers, E.W.; Rubin, G.M.;<lb/> Venter, J.C. The genome sequence of Drosophila melanogaster.<lb/> Science, 2000, 287, 2185-2195.<lb/> </bibl>
        <bibl><label>[30]</label><lb/> Campos-Ortega, J.A.; Hartenstein, V. The Embryonic Development<lb/> of Drosophila Melanogaster; Springer Verlag: Berlin and<lb/> Heidelberg, 1997.<lb/> </bibl>
        <bibl><label>[31]</label><lb/> Technau, G.M. Brain Development in Drosophila Melanogaster;<lb/> Springer Verlag: Berlin, 2008.<lb/> </bibl>
        <bibl><label>[32]</label><lb/> Ashburner, M.; Golic, K.; Hawley, S. Drosophila: A Laboratory<lb/> Handbook; Cold Spring Harbor Laboratory Press: New Jersey,<lb/> 2004.<lb/> </bibl>
        <bibl><label>[33]</label><lb/> Greenspan, R.J. Fly Pushing: The Theory and Practice of<lb/> Drosophila Genetics; Cold Spring Harbor Laboratory Press: New<lb/> Jersey 2004.<lb/> </bibl>
        <bibl><label>[34]</label><lb/> Dahmann, C. Drosophila: Methods and Protocols; Humana Press:<lb/> New York, 2008.<lb/> </bibl>
        <bibl><label>[35]</label><lb/> Heisenberg, M. Genetic approaches to neuroethology. Bioessays,<lb/> 1997, 19, 1065-1073.<lb/> </bibl>
        <bibl><label>[36]</label><lb/> Rubin, G.M.; Yandell, M.D.; Wortman, J.R.; Gabor Miklos, G.L.;<lb/> Nelson, C.R.; Hariharan, I.K.; Fortini, M.E.; Li, P.W.; Apweiler,<lb/> R.; Fleischmann, W.; Cherry, J.M.; Henikoff, S.; Skupski, M.P.;<lb/> Misra, S.; Ashburner, M.; Birney, E.; Boguski, M.S.; Brody, T.;<lb/> Brokstein, P.; Celniker, S.E.; Chervitz, S.A.; Coates, D.; Cravchik,<lb/> A.; Gabrielian, A.; Galle, R.F.; Gelbart, W.M.; George, R.A.;<lb/> Goldstein, L.S.; Gong, F.; Guan, P.; Harris, N.L.; Hay, B.A.;<lb/> Hoskins, R.A.; Li, J.; Li, Z.; Hynes, R.O.; Jones, S.J.; Kuehl, P.M.;<lb/> Lemaitre, B.; Littleton, J.T.; Morrison, D.K.; Mungall, C.;<lb/> O&apos;Farrell, P.H.; Pickeral, O.K.; Shue, C.; Vosshall, L.B.; Zhang, J.;<lb/> Zhao, Q.; Zheng, X.H.; Lewis, S. Comparative genomics of the<lb/> eukaryotes. Science, 2000, 287, 2204-2215.<lb/> </bibl>
        <bibl><label>[37]</label><lb/> Edgar, B.A.; Lehner, C.F. Developmental control of cell cycle<lb/> regulators: a fly&apos;s perspective. Science, 1996, 274, 1646-1652.<lb/> </bibl>
        <bibl><label>[38]</label><lb/> Bähler, J. Cell-cycle control of gene expression in budding and<lb/> fission yeast. Annu. Rev. Genet., 2005, 39, 69-94.<lb/> </bibl>
        <bibl><label>[39]</label><lb/> Sánchez, I.; Dynlacht, B.D. New insights into cyclins, CDKs, and<lb/> cell cycle control. Semin. Cell Dev. Biol., 2005, 16, 311-321.<lb/> </bibl>
        <bibl><label>[40]</label><lb/> Stocker, H.; Hafen, E. Genetic control of cell size. Curr. Opin.<lb/> Genet. Dev., 2000, 10, 529-535.<lb/> </bibl>
        <bibl><label>[41]</label><lb/> Hietakangas, V.; Cohen, S.M. Regulation of tissue growth through<lb/> nutrient sensing. Annu. Rev. Genet., 2009, 43, 389-410.<lb/> </bibl>
        <bibl><label>[42]</label><lb/> Leuzinger, S.; Hirth, F.; Gerlich, D.; Acampora, D.; Simeone, A.;<lb/> Gehring, W.J.; Finkelstein, R.; Furukubo-Tokunaga, K.; Reichert,<lb/> H. Equivalence of the fly orthodenticle gene and the human OTX<lb/> genes in embryonic brain development of Drosophila.<lb/> Development, 1998, 125, 1703-1710.<lb/> </bibl>
        <bibl><label>[43]</label><lb/> Nagao, T.; Leuzinger, S.; Acampora, D.; Simeone, A.; Finkelstein,<lb/> R.; Reichert, H.; Furukubo-Tokunaga, K. Developmental rescue of<lb/> Drosophila cephalic defects by the human Otx genes. Proc. Natl.<lb/> Acad. Sci. USA, 1998, 95, 3737-3742.<lb/> </bibl>
        <bibl><label>[44]</label><lb/> Hanks, M.C.; Loomis, C.A.; Harris, E.; Tong, C.X.; Anson-<lb/>Cartwright, L.; Auerbach, A.; Joyner, A. Drosophila engrailed can<lb/> substitute for mouse Engrailed1 function in mid-hindbrain, but not<lb/> limb development. Development, 1998, 125, 4521-4530.<lb/> </bibl>
        <bibl><label>[45]</label><lb/> Hirth, F.; Reichert, H. Conserved genetic programs in insect and<lb/> mammalian brain development. Bioessays, 1999, 21, 677-84.<lb/> </bibl>
        <bibl><label>[46]</label><lb/> Reiter, L.T.; Potocki, L.; Chien, S.; Gribskov, M.; Bier, E. A<lb/> systematic analysis of human disease-associated gene sequences in<lb/> Drosophila melanogaster. Genome Res., 2001, 11, 1114-1125.<lb/> </bibl>
        <bibl><label>[47]</label><lb/> Brand, A.H.; Perrimon, N. Targeted gene expression as a means of<lb/> altering cell fates and generating dominant phenotypes.<lb/> Development, 1993, 118, 401-15.<lb/> </bibl>
        <bibl><label>[48]</label><lb/> Sang, T.K.; Jackson, G.R. Drosophila models of neurodegenerative<lb/> disease. NeuroRx, 2005, 2, 438-46.<lb/> </bibl>
        <bibl><label>[49]</label><lb/> Kramer, J.M.; Staveley, B.E. GAL4 causes developmental defects<lb/> and apoptosis when expressed in the developing eye of Drosophila<lb/> melanogaster. Genet. Mol. Res., 2003, 2, 43-47.<lb/> </bibl>
        <bibl><label>[50]</label><lb/> Bischof, J.; Basler, K. Recombinases and their use in gene<lb/> activation, gene inactivation, and transgenesis. Methods Mol. Biol.,<lb/> 2008, 420, 175-195.<lb/> </bibl>
        <bibl><label>[51]</label><lb/> Leung, B.; Waddell, S. Four-dimensional gene expression control:<lb/> memories on the fly. Trends Neurosci., 2004, 27, 511-513.<lb/> </bibl>
        <bibl><label>[52]</label><lb/> Bier, E. Drosophila, the golden bug, emerges as a tool for human<lb/> genetics. Nat. Rev. Genet., 2005, 6, 9-23.<lb/> </bibl>
        <bibl><label>[53]</label><lb/> Venken, K.J.; Bellen, H.J. Transgenesis upgrades for Drosophila<lb/> melanogaster. Development, 2007, 134, 3571-3584.<lb/> </bibl>
        <bibl><label>[54]</label><lb/> Venken, K.J.; Bellen, H.J. Emerging technologies for gene<lb/> manipulation in Drosophila melanogaster. Nat. Rev. Genet., 2005,<lb/> 6, 167-178.<lb/> </bibl>
        <bibl><label>[55]</label><lb/> Dietzl, G.; Chen, D.; Schnorrer, F.; Su, K.C.; Barinova, Y.; Fellner,<lb/> M.; Gasser, B.; Kinsey, K.; Oppel, S.; Scheiblauer, S.; Couto, A.;<lb/> Marra, V.; Keleman, K.; Dickson, B.J. A genome-wide transgenic<lb/> RNAi library for conditional gene inactivation in Drosophila.<lb/> Nature, 2007, 448, 151-156.<lb/> </bibl>
        <bibl><label>[56]</label><lb/> Dodson, M.W.; Guo, M. Pink1, Parkin, DJ-1 and mitochondrial<lb/> dysfunction in Parkinson&apos;s disease. Curr. Opin. Neurobiol., 2007,<lb/> 17, 331-337.<lb/> </bibl>
        <bibl><label>[57]</label><lb/> Park, J.; Kim, Y.; Chung, J. Mitochondrial dysfunction and<lb/> Parkinson&apos;s disease genes: insights from Drosophila. Dis. Model<lb/> Mech., 2009, 2, 336-340.<lb/> </bibl>
        <bibl><label>[58]</label><lb/> Van Laar, V.S.; Berman, S.B. Mitochondrial dynamics in<lb/> Parkinson&apos;s disease. Exp. Neurol., 2009, 218, 247-256.<lb/> </bibl>
        <bibl><label>[59]</label><lb/> Shulman, J.M.; Feany, M.B. Genetic modifiers of tauopathy in<lb/> Drosophila. Genetics, 2003, 165, 1233-1242.<lb/> </bibl>
        <bibl><label>[60]</label><lb/> Scherzer, C.R.; Jensen, R.V.; Gullans, S.R.; Feany, M.B. Gene<lb/> expression changes presage neurodegeneration in a Drosophila<lb/> model of Parkinson&apos;s disease. Hum. Mol. Genet., 2003, 12, 2457-<lb/>2466.<lb/> </bibl>
        <bibl><label>[61]</label><lb/> Whitworth, A.J.; Theodore, D.A.; Greene, J.C.; Benes, H.; Wes,<lb/> P.D.; Pallanck, L.J. Increased glutathione S-transferase activity<lb/> rescues dopaminergic neuron loss in a Drosophila model of<lb/> Parkinson&apos;s disease. Proc. Natl. Acad. Sci. USA, 2005, 102, 8024-<lb/>8029.<lb/> </bibl>
        <bibl><label>[62]</label><lb/> Karsten, S.L.; Sang, T.K.; Gehman, L.T.; Chatterjee, S.; Liu, J.;<lb/> Lawless, G.M.; Sengupta, S.; Berry, R.W.; Pomakian, J.; Oh, H.S.;<lb/> Schulz, C.; Hui, K.S.; Wiedau-Pazos, M.; Vinters, H.V.; Binder,<lb/> L.I.; Geschwind, D.H.; Jackson, G.R. A genomic screen for<lb/> modifiers<lb/> of<lb/> tauopathy<lb/> identifies<lb/> puromycin-sensitive<lb/> aminopeptidase as an inhibitor of tau-induced neurodegeneration.<lb/> Neuron, 2006, 51, 549-560.<lb/> </bibl>
        <bibl><label>[63]</label><lb/> Cooper, A.A.; Gitler, A.D.; Cashikar, A.; Haynes, C.M.; Hill, K.J.;<lb/> Bhullar, B.; Liu, K.; Xu, K.; Strathearn, K.E.; Liu, F.; Cao, S.;<lb/> Caldwell, K.A.; Caldwell, G.A.; Marsischky, G.; Kolodner, R.D.;<lb/> Labaer, J.; Rochet, J.C.; Bonini, N.M.; Lindquist, S. Alpha-<lb/>synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in<lb/> Parkinson&apos;s models. Science, 2006, 313, 324-328.<lb/> </bibl>
        <bibl><label>[64]</label><lb/> Blard, O.; Feuillette, S.; Bou, J.; Chaumette, B.; Frébourg, T.;<lb/> Campion, D.; Lecourtois, M. Cytoskeleton proteins are modulators<lb/> of mutant tau-induced neurodegeneration in Drosophila. Hum. Mol.<lb/> Genet., 2007, 16, 555-566.<lb/> </bibl>
        <bibl><label>[65]</label><lb/> Tan, L.; Schedl, P.; Song, H.J.; Garza, D.; Konsolaki, M. The<lb/> Toll--&gt;NFkappaB signaling pathway mediates the neuropatho-<lb/>logical effects of the human Alzheimer&apos;s Abeta42 polypeptide in<lb/> Drosophila. PLoS One, 2008, 3, e3966.<lb/> </bibl>
        <bibl><label>[66]</label><lb/> Outeiro, T.F.; Kontopoulos, E.; Altmann, S.M.; Kufareva, I.;<lb/> Strathearn, K.E.; Amore, A.M.; Volk, C.B.; Maxwell, M.M.;<lb/> Rochet, J.C.; McLean, P.J.; Young, A.B.; Abagyan, R.; Feany,<lb/> M.B.; Hyman, B.T.; Kazantsev, A.G. Sirtuin 2 inhibitors rescue<lb/> alpha-synuclein-mediated toxicity in models of Parkinson&apos;s disease.<lb/> Science, 2007, 317, 516-519.<lb/> </bibl>
        <bibl><label>[67]</label><lb/> Rajendran, L.; Schneider, A.; Schlechtingen, G.; Weidlich, S.;<lb/> Ries, J.; Braxmeier, T.; Schwille, P.; Schulz, J.B.; Schroeder, C.;<lb/> Simons, M.; Jennings, G.; Knölker, H.J.; Simons, K. Efficient<lb/> inhibition of the Alzheimer&apos;s disease beta-secretase by membrane<lb/> targeting. Science, 2008, 320, 520-523.<lb/> </bibl>
        <bibl><label>[68]</label><lb/> Auluck, P.K.; Meulener, M.C.; Bonini, N.M. Mechanisms of<lb/> Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin<lb/> in Drosophila. J. Biol. Chem., 2005, 280, 2873-2878.<lb/> </bibl>
        <bibl><label>[69]</label><lb/> Faust, K.; Gehrke, S.; Yang, Y.; Yang, L.; Beal, M.F.; Lu, B.<lb/> Neuroprotective effects of compounds with antioxidant and anti-<lb/>inflammatory properties in a Drosophila model of Parkinson&apos;s<lb/> disease. BMC Neurosci., 2009, 10, 109.<lb/> </bibl>
        <bibl><label>[70]</label><lb/> Chang, S.; Bray, S.M.; Li, Z.; Zarnescu, C.D.; He, C.; Jin, C.;<lb/> Warren, S.T. Identification of small molecules rescuing fragile X<lb/> syndrome phenotypes in Drosophila. Nat. Chem. Biol., 2008, 4,<lb/> 256-263.<lb/> </bibl>
        <bibl><label>[71]</label><lb/> Stork, T.; Engelen, D.; Krudewig, A.; Silies, M.; Bainton, R.J.;<lb/> Klambt, C. Organization and function of the blood-brain barrier in<lb/> Drosophila. J. Neurosci., 2008, 28, 587-597.<lb/> </bibl>
        <bibl><label>[72]</label><lb/> Vidal, M.; Cagan, R.L. Drosophila models for cancer research.<lb/> Curr. Opin. Genet. Dev., 2006, 16, 10-16.<lb/> </bibl>
        <bibl><label>[73]</label><lb/> Zoghbi, H.Y.; Botas, J. Mouse and fly models of<lb/> neurodegeneration. Trends Genet., 2002, 18, 463-471.<lb/> </bibl>
        <bibl><label>[74]</label><lb/> Bonini, N.M.; Fortini, M.E. Human neurodegenerative disease<lb/> modeling using Drosophila. Annu. Rev. Neurosci., 2003, 26, 627-<lb/>659.<lb/> </bibl>
        <bibl><label>[75]</label><lb/> O&apos;Kane, C.J. Modelling human diseases in Drosophila and<lb/> Caenorhabditis. Semin Cell Dev. Biol., 2003, 14, 3-10.<lb/> </bibl>
        <bibl><label>[76]</label><lb/> Driscoll, M.; Gerstbrein, B. Dying for a cause: invertebrate<lb/> genetics takes on human neurodegeneration. Nat. Rev. Genet.,<lb/> 2003, 4, 181-194.<lb/> </bibl>
        <bibl><label>[77]</label><lb/> Shulman, J.M.; Shulman, L.M.; Weiner, W.J.; Feany, M.B. From<lb/> fruit fly to bedside: translating lessons from Drosophila models of<lb/> neurodegenerative disease. Curr. Opin. Neurol., 2003, 16, 443-449.<lb/> </bibl>
        <bibl><label>[78]</label><lb/> Marsh, J.L.; Thompson, L.M. Can flies help humans treat<lb/> neurodegenerative diseases? Bioessays, 2004, 26, 485-496.<lb/> </bibl>
        <bibl><label>[79]</label><lb/> Cauchi, R.J.; van den Heuvel, M. The fly as a model for<lb/> neurodegenerative diseases: is it worth the jump? Neurodegener.<lb/> Dis., 2006, 3, 338-356.<lb/> </bibl>
        <bibl><label>[80]</label><lb/> Iijima, K.; Iijima-Ando, K. Drosophila models of Alzheimer&apos;s<lb/> amyloidosis: the challenge of dissecting the complex mechanisms<lb/> of toxicity of amyloid-beta 42. J. Alzheimers Dis., 2008, 15, 523-<lb/>540.<lb/> </bibl>
        <bibl><label>[81]</label><lb/> Khurana, V. Modeling Tauopathy in the fruit fly Drosophila<lb/> melanogaster. J. Alzheimers Dis., 2008, 15, 541-553.<lb/> </bibl>
        <bibl><label>[82]</label><lb/> Lu, B.; Vogel, H. Drosophila models of neurodegenerative<lb/> diseases. Annu. Rev. Pathol. Mech. Dis., 2009, 4, 315-342.<lb/> </bibl>
        <bibl><label>[83]</label><lb/> Lu, B. Recent advances in using Drosophila to model<lb/> neurodegenerative diseases. Apoptosis, 2009, 14, 1008-1020.<lb/> </bibl>
        <bibl><label>[84]</label><lb/> McPhee, C.K.; Baehrecke, E.H. Autophagy in Drosophila<lb/> melanogaster. Biochim. Biophys. Acta, 2009, 1793, 1452-1460.<lb/> </bibl>
        <bibl><label>[85]</label><lb/> Lessing, D.; Bonini, N.M. Maintaining the brain: insight into<lb/> human neurodegeneration from Drosophila melanogaster mutants.<lb/> Nat. Rev. Genet., 2009, 10, 359-370.<lb/> </bibl>
        <bibl><label>[86]</label><lb/> Goedert, M.; Spillantini, M.G. A century of Alzheimer&apos;s disease.<lb/> Science, 2006, 314, 777-781.<lb/> </bibl>
        <bibl><label>[87]</label><lb/> Hardy, J. A hundred years of Alzheimer&apos;s disease research. Neuron,<lb/> 2006, 52, 3-13.<lb/> </bibl>
        <bibl><label>[88]</label><lb/> Bu, G. Apolipoprotein E and its receptors in Alzheimer&apos;s disease:<lb/> pathways, pathogenesis and therapy. Nat. Rev. Neurosci., 2009, 10,<lb/> 333-344.<lb/> </bibl>
        <bibl><label>[89]</label><lb/> Braak, H.; Del Tredici, K. Invited Article: Nervous system<lb/> pathology in sporadic Parkinson disease. Neurology, 2008, 70,<lb/> 1916-1925.<lb/> </bibl>
        <bibl><label>[90]</label><lb/> Nelson, P.T.; Braak, H.; Markesbery, W.R. Neuropathology and<lb/> cognitive impairment in Alzheimer disease: a complex but coherent<lb/> relationship. J. Neuropathol. Exp. Neurol., 2009, 68, 1-14.<lb/> </bibl>
        <bibl><label>[91]</label><lb/> Lee, V.; Goedert, M.; Trojanowski, J.Q. Neurodegenerative<lb/> Tauopathies. Annu. Rev. Neurosci., 2001, 24, 1121-1159.<lb/> </bibl>
        <bibl><label>[92]</label><lb/> Ballatore, C.; Lee, V.M.; Trojanowski, J.Q. Tau-mediated<lb/> neurodegeneration in Alzheimer&apos;s disease and related disorders.<lb/> Nat. Rev. Neurosci., 2007, 8, 663-672.<lb/> </bibl>
        <bibl><label>[93]</label><lb/> Hardy, J.; Selkoe, D.J. The amyloid hypothesis of Alzheimer&apos;s<lb/> disease: progress and problems on the road to therapeutics. Science,<lb/> 2002, 297, 353-356.<lb/> </bibl>
        <bibl><label>[94]</label><lb/> Hardy, J. The amyloid hypothesis for Alzheimer&apos;s disease: a<lb/> critical reappraisal. J. Neurochem. 2009, 110, 1129-1134.<lb/> </bibl>
        <bibl><label>[95]</label><lb/> Luo, L.; Tully, T.; White, K. Human amyloid precursor protein<lb/> ameliorates behavioral deficit of flies deleted for Appl gene.<lb/> Neuron, 1992, 9, 595-605.<lb/> </bibl>
        <bibl><label>[96]</label><lb/> Carmine-Simmen, K.; Proctor, T.; Tschäpe, J.; Poeck, B.; Triphan,<lb/> T.; Strauss, R.; Kretzschmar, D. Neurotoxic effects induced by the<lb/> Drosophila amyloid-beta peptide suggest a conserved toxic<lb/> function. Neurobiol. Dis., 2009, 33, 274-281.<lb/> </bibl>
        <bibl><label>[97]</label><lb/> Greeve, I.; Kretzschmar, D.; Tschape, J.A.; Beyn, A.; Brellinger,<lb/> C.; Schweizer, M.; Nitsch, R.M.; Reifegerste, R. Age-dependent<lb/> neurodegeneration and Alzheimer-amyloid plaque formation in<lb/> transgenic Drosophila. J. Neurosci., 2004, 24, 3899-3906.<lb/> </bibl>
        <bibl><label>[98]</label><lb/> Iijima, K.; Liu, H.P.; Chiang, A.S.; Hearn, S.A.; Konsolaki, M.;<lb/> Zhong, Y. Dissecting the pathological effects of human Abeta40<lb/> and Abeta42 in Drosophila: a potential model for Alzheimer&apos;s<lb/> disease. Proc. Natl. Acad. Sci. USA, 2004, 101, 6623-6628.<lb/> </bibl>
        <bibl><label>[99]</label><lb/> Torroja, L.; Chu, H.; Kotovsky, I.; White, K. Neuronal<lb/> overexpression of APPL, the Drosophila homologue of the amyloid<lb/> precursor protein (APP), disrupts axonal transport. Curr. Biol.,<lb/> 1999, 9, 489-492.<lb/> </bibl>
        <bibl><label>[100]</label> Gunawardena, S.; Goldstein, L.S. Disruption of axonal transport<lb/> and neuronal viability by amyloid precursor protein mutations in<lb/> Drosophila. Neuron, 2001, 32, 389-401.<lb/> </bibl>
        <bibl><label>[101]</label> Stokin, G.B.; Almenar-Queralt, A.; Gunawardena, S.; Rodrigues,<lb/> E.M.; Falzone, T.; Kim, J.; Lillo, C.; Mount, S.L.; Roberts, E.A.;<lb/> McGowan, E.; Williams, D.S.; Goldstein, L.S. Amyloid precursor<lb/> protein-induced axonopathies are independent of amyloid-beta<lb/> peptides. Hum. Mol. Genet., 2008, 17, 3474-3486.<lb/> </bibl>
        <bibl><label>[102]</label> Iijima-Ando, K.; Hearn, S.A.; Shenton, C.; Gatt, A.; Zhao, L.;<lb/> Iijima, K. Mitochondrial mislocalization underlies abeta42-induced<lb/> neuronal dysfunction in a Drosophila model of Alzheimer&apos;s disease.<lb/> PLoS One, 2009, 4, e8310.<lb/> </bibl>
        <bibl><label>[103]</label> Rusu, P.; Jansen, A.; Soba, P.; Kirsch, J.; Löwer, A.; Merdes, G.;<lb/> Kuan, Y.H.; Jung, A.; Beyreuther, K.; Kjaerulff, O.; Kins, S.<lb/> Axonal accumulation of synaptic markers in APP transgenic<lb/> Drosophila depends on the NPTY motif and is paralleled by defects<lb/> in synaptic plasticity. Eur. J. Neurosci., 2007, 25, 1079-1086.<lb/> </bibl>
        <bibl><label>[104]</label> Crowther, D.C.; Kinghorn, K.J.; Miranda, E.; Page, R.; Curry, J.A.;<lb/> Duthie, F.A.; Gubb, D.C.; Lomas, D.A. Intraneuronal Abeta, non-<lb/>amyloid aggregates and neurodegeneration in a Drosophila model<lb/> of Alzheimer&apos;s disease. Neuroscience, 2005, 132, 123-135.<lb/> </bibl>
        <bibl><label>[105]</label> Iijima, K.; Chiang, H.C.; Hearn, S.A.; Hakker, I.; Gatt, A.;<lb/> Shenton, C.; Granger, L.; Leung, A.; Iijima-Ando, K.; Zhong, Y.<lb/> Abeta42 mutants with different aggregation profiles induce distinct<lb/> pathologies in Drosophila. PLoS One, 2008, 3, e1703.<lb/> </bibl>
        <bibl><label>[106]</label> van de Hoef, D.L.; Hughes, J.; Livne-Bar, I.; Garza, D.; Konsolaki,<lb/> M.; Boulianne, G.L. Identifying genes that interact with Drosophila<lb/> presenilin and amyloid precursor protein. Genesis, 2009, 47, 246-<lb/>260.<lb/> </bibl>
        <bibl><label>[107]</label> Finelli, A.; Kelkar, A.; Song, H.J.; Yang, H.; Konsolaki, M. A<lb/> model for studying Alzheimer&apos;s Abeta42-induced toxicity in<lb/> Drosophila melanogaster. Mol. Cell. Neurosci., 2004, 26, 365-375.<lb/> </bibl>
        <bibl><label>[108]</label> Iijima-Ando, K.; Hearn, S.A.; Granger, L.; Shenton, C.; Gatt, A.;<lb/> Chiang, H.C.; Hakker, I.; Zhong, Y.; Iijima, K. Overexpression of<lb/> neprilysin reduces alzheimer amyloid-beta42 (Abeta42)-induced<lb/> neuron loss and intraneuronal Abeta42 deposits but causes a<lb/> reduction in cAMP-responsive element-binding protein-mediated<lb/> transcription, age-dependent axon pathology, and premature death<lb/> in Drosophila. J. Biol. Chem., 2008, 283, 19066-19076.<lb/> </bibl>
        <bibl><label>[109]</label> Sanokawa-Akakura, R.; Cao, W.; Allan, K.; Patel, K.; Ganesh, A.;<lb/> Heiman, G.; Burke, R.; Kemp, F.W.; Bogden, J.D.; Camakaris, J.;<lb/> Birge, R.B.; Konsolaki, M. Control of Alzheimer&apos;s amyloid beta<lb/> toxicity by the high molecular weight immunophilin FKBP52 and<lb/> copper homeostasis in Drosophila. PLoS One 2010, 5, e8626.<lb/> </bibl>
        <bibl><label>[110]</label> Schilling, S.; Zeitschel, U.; Hoffmann, T.; Heiser, U.; Francke, M.;<lb/> Kehlen, A.; Holzer, M.; Hutter-Paier, B.; Prokesch, M.; Windisch,<lb/> M.; Jagla, W.; Schlenzig, D.; Lindner, C.; Rudolph, T.; Reuter, G.;<lb/> Cynis, H.; Montag, D.; Demuth, H.U.; Rossner, S. Glutaminyl<lb/> cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer&apos;s<lb/> disease-like pathology. Nat. Med., 2008, 14, 1106-1111.<lb/> </bibl>
        <bibl><label>[111]</label> Ling, D.; Song, H.J.; Garza, D.; Neufeld, T.P.; Salvaterra, P.M.<lb/> Abeta42-induced neurodegeneration via an age-dependent<lb/> autophagic-lysosomal injury in Drosophila. PLoS One, 2009, 4,<lb/> e4201.<lb/> </bibl>
        <bibl><label>[112]</label> Leyssen, M.; Ayaz, D.; Hébert, S.S.; Reeve, S.; De Strooper, B.;<lb/> Hassan, B.A. Amyloid precursor protein promotes post-<lb/>developmental neurite arborization in the Drosophila brain. EMBO<lb/> J., 2005, 24, 2944-2955.<lb/> </bibl>
        <bibl><label>[113]</label> Nixon, R.A. Autophagy, amyloidogenesis and Alzheimer disease.<lb/> J. Cell. Sci., 2007, 120, 4081-4091.<lb/> </bibl>
        <bibl><label>[114]</label> Erol, A. Unraveling the molecular mechanisms behind the<lb/> metabolic basis of sporadic Alzheimer&apos;s disease. J. Alzheimers Dis.,<lb/> 2009, 17, 267-276.<lb/> </bibl>
        <bibl><label>[115]</label> Haass, C.; Selkoe, D.J. Soluble protein oligomers in<lb/> neurodegeneration: lessons from the Alzheimer&apos;s amyloid beta-<lb/>peptide. Nat. Rev. Mol. Cell. Biol., 2007, 8, 101-112.<lb/> </bibl>
        <bibl><label>[116]</label> Harmeier, A.; Wozny, C.; Rost, B.R.; Munter, L.M.; Hua, H.;<lb/> Georgiev, O.; Beyermann, M.; Hildebrand, P.W.; Weise, C.;<lb/> Schaffner, W.; Schmitz, D.; Multhaup, G. Role of amyloid-beta<lb/> glycine 33 in oligomerization, toxicity, and neuronal plasticity. J.<lb/> Neurosci., 2009, 29, 7582-7590.<lb/> </bibl>
        <bibl><label>[117]</label> Ye, Y.; Lukinova, N.; Fortini, M.E. Neurogenic phenotypes and<lb/> altered Notch processing in Drosophila Presenilin mutants. Nature,<lb/> 1999, 398, 525-529.<lb/> </bibl>
        <bibl><label>[118]</label> Fiúza, U.M.; Arias, A.M. Cell and molecular biology of Notch. J.<lb/> Endocrinol., 2007, 194, 459-474.<lb/> </bibl>
        <bibl><label>[119]</label> Seidner, G.A.; Ye, Y.; Faraday, M.M.; Alvrod, W.G.; Fortini, M.E.<lb/> Modeling clinically heterogenous presenilin mutations with<lb/> transgenic Drosophila. Curr. Biol., 2006, 16, 1026-1033.<lb/> </bibl>
        <bibl><label>[120]</label> Li, A.; Xie, Z.; Dong, Y.; McKay, K.M.; McKee, M.L.; Tanzi, R.E.<lb/> Isolation and characterization of the Drosophila ubiquilin ortholog<lb/> dUbqln: in vivo interaction with early-onset Alzheimer disease<lb/> genes. Hum. Mol. Genet., 2007, 16, 2626-2639.<lb/> </bibl>
        <bibl><label>[121]</label> Ganguly, A.; Feldman, R.M.; Guo, M. ubiquilin antagonizes<lb/> presenilin and promotes neurodegeneration in Drosophila. Hum.<lb/> Mol. Genet., 2008, 17, 293-302.<lb/> </bibl>
        <bibl><label>[122]</label> Michno, K.; Knight, D.; Campusano, J.M.; van de Hoef, D.;<lb/> Boulianne, G.L. Intracellular calcium deficits in Drosophila<lb/> cholinergic neurons expressing wild type or FAD-mutant<lb/> presenilin. PLoS One, 2008, 4, e6904.<lb/> </bibl>
        <bibl><label>[123]</label> Bezprozvanny, I.; Mattson, M.P. Neuronal calcium mishandling<lb/> and the pathogenesis of Alzheimer&apos;s disease. Trends Neurosci.,<lb/> 2008, 31, 454-463.<lb/> </bibl>
        <bibl><label>[124]</label> Dehmelt, L.; Halpain, S. The MAP2/Tau family of microtubule-<lb/>associated proteins. Genome Biol. 2005, 6, 204.<lb/> </bibl>
        <bibl><label>[125]</label> Gasparini, L.; Terni, B.; Spillantini, M.G. Frontotemporal dementia<lb/> with Tau pathology. Neurodegen. Dis., 2007, 4, 236-253.<lb/> </bibl>
        <bibl><label>[126]</label> Heidary, G.; Fortini, M.E. Identification and characterization of the<lb/> Drosophila tau homolog. Mech. Dev., 2001, 108, 171-178.<lb/> </bibl>
        <bibl><label>[127]</label> Mershin, A.; Pavlopoulos, E.; Fitch, O.; Braden, B.C.; Nanopoulos,<lb/> D.V.; Skoulakis, E.M. Learning and memory deficits upon TAU<lb/> accumulation in Drosophila mushroom body neurons. Learn.<lb/> Mem., 2004, 11, 277-287.<lb/> </bibl>
        <bibl><label>[128]</label> Steinhilb, M.L.; Dias-Santagata, D.; Fulga, T.A.; Felch, D.L.;<lb/> Feany, M.B. Tau phosphorylation sites work in concert to promote<lb/> neurotoxicity in vivo. Mol. Biol. Cell, 2007, 18, 5060-5068.<lb/> </bibl>
        <bibl><label>[129]</label> Chatterjee, S.; Sang, T.K.; Lawless, G.M.; Jackson, G.R.<lb/> Dissociation of tau toxicity and phosphorylation: role of GSK-<lb/>3beta, MARK and Cdk5 in a Drosophila model. Hum. Mol. Genet.<lb/> 2009, 18, 164-77.<lb/> </bibl>
        <bibl><label>[130]</label> Wittmann, C.W.; Wszolek, M.F.; Shulman, J.M.; Salvaterra, P.M.;<lb/> Lewis, J.; Hutton, M.; Feany, M.B. Tauopathy in Drosophila:<lb/> neurodegeneration without neurofibrillary tangles. Science, 2001,<lb/> 293, 711-714.<lb/> </bibl>
        <bibl><label>[131]</label> Fulga, T.A.; Elson-Schwab, I.; Khurana, V.; Steinhilb, M.L.;<lb/> Spires, T.L.; Hyman, B.T.; Feany, M.B. Abnormal bundling and<lb/> accumulation of F-actin mediates tau-induced neuronal<lb/> degeneration in vivo. Nat. Cell Biol., 2007, 9, 139-148.<lb/> </bibl>
        <bibl><label>[132]</label> Jackson, G.R.; Wiedau-Pazos, M.; Sang, T-K.; Wagle, N.; Brown,<lb/> C.A.; Massachi, S.; Geschwind, D.H. Human wild-type tau<lb/> interacts with wingless pathway components and produces<lb/> neurofibrillary pathology in Drosophila. Neuron, 2002, 34, 509-<lb/>519.<lb/> </bibl>
        <bibl><label>[133]</label> Wang, J.W.; Imai, Y.; Lu, B. Activation of PAR-1 kinase and<lb/> stimulation of tau phosphorylation by diverse signals require the<lb/> tumor suppressor protein LKB1. J. Neurosci., 2007, 27, 574-581.<lb/> </bibl>
        <bibl><label>[134]</label> Karsten, S.L.; Sang, T.K.; Gehman, L.T.; Chatterjee, S.; Liu, J.;<lb/> Lawless, G.M.; Sengupta, S.; Berry, R.W.; Pomakian, J.; Oh, H.S.;<lb/> Schulz, C.; Hui, K.S.; Wiedau-Pazos, M.; Vinters, H.V.; Binder,<lb/> L.I.; Geschwind, D.H.; Jackson, G.R. A genomic screen for<lb/> modifiers<lb/> of<lb/> tauopathy<lb/> identifies<lb/> puromycin-sensitive<lb/> aminopeptidase as an inhibitor of tau-induced neurodegeneration.<lb/> Neuron, 2006, 51, 549-60.<lb/> </bibl>
        <bibl><label>[135]</label> Dias-Santagata, D.; Fulga, T.A.; Duttaroy, A.; Feany, M.B.<lb/> Oxidative stress mediates tau-induced neurodegeneration in<lb/> Drosophila. J. Clin. Invest., 2007, 117, 236-245.<lb/> </bibl>
        <bibl><label>[136]</label> Khurana, V.; Lu, Y.; Steinhilb, M.L.; Oldham, S.; Shulman, J.M.;<lb/> Feany, M.B. TOR-mediated cell-cycle activation causes<lb/> neurodegeneration in a Drosophila tauopathy model. Curr. Biol.,<lb/> 2006, 16, 230-241.<lb/> </bibl>
        <bibl><label>[137]</label> Kim, D.; Tsai, L.H. Linking cell cycle reentry and DNA damage in<lb/> neurodegeneration. Ann. NY Acad. Sci., 2009, 1170, 674-679.<lb/> </bibl>
        <bibl><label>[138]</label> Berger, Z.; Ravikumar, B.; Menzies, F.M.; Oroz, L.G.;<lb/> Underwood, B.R.; Pangalos, M.N.; Schmitt, I.; Wullner, U.; Evert,<lb/> B.O.; O&apos;Kane, C.J.; Rubinsztein, D.C. Rapamycin alleviates<lb/> toxicity of different aggregate-prone proteins. Hum. Mol. Genet.,<lb/> 2006, 15, 433-442.<lb/> </bibl>
        <bibl><label>[139]</label> Hanger, D.P.; Anderton, B.H.; Noble, W. Tau phosphorylation: the<lb/> therapeutic challenge for neurodegenerative disease. Trends Mol.<lb/> Med., 2009, 15, 112-119.<lb/> </bibl>
        <bibl><label>[140]</label> Farrer, M.J. Genetics of Parkinson disease: Paradigm shifts and<lb/> future prospects. Nat. Rev. Genet., 2006, 7, 303-318.<lb/> </bibl>
        <bibl><label>[141]</label> Lees, A.J.; Hardy, J.; Revesz, T. Parkinson&apos;s disease. The Lancet,<lb/> 2009, 373, 2055-2066.<lb/> </bibl>
        <bibl><label>[142]</label> Dauer, W.; Przedborski, S. Parkinson&apos;s disease: mechanisms and<lb/> models. Neuron, 2003, 39, 889-909.<lb/> </bibl>
        <bibl><label>[143]</label> Moore, D.J.; West, A.B.; Dawson, V.L.; Dawson, T.M. Molecular<lb/> pathophysiology of Parkinson&apos;s disease. Annu. Rev. Neurosci.,<lb/> 2005, 28, 57-87.<lb/> </bibl>
        <bibl><label>[144]</label> Thomas, B.; Beal, M.F. Parkinson&apos;s disease. Hum. Mol. Genet.,<lb/> 2007, 16(Spec No. 2), R183-194.<lb/> </bibl>
        <bibl><label>[145]</label> Hardy, J.; Lewis, P.; Revesz, T.; Lees, A.; Paisan-Ruiz, C. The<lb/> genetics of Parkinson&apos;s syndromes: a critical review. Curr. Opin.<lb/> Genet. Dev., 2009, 19, 254-265.<lb/> </bibl>
        <bibl><label>[146]</label> Shulman, J.M.; de Jager, P.L. Evidence for a common pathway<lb/> linking neurodegenerative diseases. Nat. Genet., 2009, 41, 1261-<lb/>1262.<lb/> </bibl>
        <bibl><label>[147]</label> Bogaerts, V.; Theuns, J.; van Broeckhoven, C. Genetic findings in<lb/> Parkinson&apos;s disease and translation into treatment: a leading role<lb/> for mitochondria? Genes Brain Behav., 2008, 7, 129-151.<lb/> </bibl>
        <bibl><label>[148]</label> Wood-Kaczmar, A.; Gandhi, S.; Wood, N.W. Understanding the<lb/> molecular causes of Parkinson&apos;s disease. Trends Mol. Med., 2006,<lb/> 12, 521-528.<lb/> </bibl>
        <bibl><label>[149]</label> Monastirioti, M. Biogenic amine systems in the fruit fly<lb/> Drosophila melanogaster. Microsc. Res. Tech., 1999, 45, 106-121.<lb/> </bibl>
        <bibl><label>[150]</label> Yellman, C.; Tao, H.; He, B.; Hirsh, J. Conserved and sexually<lb/> dimorphic behavioral responses to biogenic amines in decapitated<lb/> Drosophila. Proc. Natl. Acad. Sci. USA, 1997, 94, 4131-4136.<lb/> </bibl>
        <bibl><label>[151]</label> Lima, S.Q.; Miesenböck, G. Remote control of behavior through<lb/> genetically targeted photostimulation of neurons. Cell, 2005, 121,<lb/> 141-152.<lb/> </bibl>
        <bibl><label>[152]</label> Feany, M.B.; Bender, W. A Drosophila model of Parkinson&apos;s<lb/> disease. Nature, 2000, 404, 394-398.<lb/> </bibl>
        <bibl><label>[153]</label> Auluck, P.K.; Chan, H.Y.; Trojanowski, J.Q.; Lee, V.M.; Bonini,<lb/> N.M. Chaperone suppression of alpha-synuclein toxicity in a<lb/> Drosophila model for Parkinson&apos;s disease. Science, 2002, 295,<lb/> 865-868.<lb/> </bibl>
        <bibl><label>[154]</label> Yang, Y.; Nishimura, I.; Imai, Y.; Takahashi, R.; Lu, B. Parkin<lb/> suppresses dopaminergic neuron-selective neurotoxicity induced by<lb/> Pael-R in Drosophila. Neuron, 2003, 37, 911-924.<lb/> </bibl>
        <bibl><label>[155]</label> Haywood, A.F.; Staveley, B.E. Parkin counteracts symptoms in a<lb/> Drosophila model of Parkinson&apos;s disease. BMC Neurosci., 2004, 5,<lb/> 14.<lb/> </bibl>
        <bibl><label>[156]</label> Haywood, A.F.; Staveley, B.E. Mutant alpha-synuclein-induced<lb/> degeneration is reduced by parkin in a fly model of Parkinson&apos;s<lb/> disease. Genome, 2006, 49, 505-510.<lb/> </bibl>
        <bibl><label>[157]</label> Periquet, M.; Fulga, T.; Myllykangas, L.; Schlossmacher, M.G.;<lb/> Feany, M.B. Aggregated alpha-synuclein mediates dopaminergic<lb/> neurotoxicity in vivo. J. Neurosci., 2007, 27, 3338-3346.<lb/> </bibl>
        <bibl><label>[158]</label> Botella, J.A.; Bayersdorfer, F.; Schneuwly, S. Superoxide<lb/> dismutase overexpression protects dopaminergic neurons in a<lb/> Drosophila model of Parkinson&apos;s disease. Neurobiol. Dis., 2008,<lb/> 30, 65-73.<lb/> </bibl>
        <bibl><label>[159]</label> Todd, A.M.; Staveley, B.E. Pink1 suppresses alpha-synuclein-<lb/>induced phenotypes in a Drosophila model of Parkinson&apos;s disease.<lb/> Genome, 2008, 51, 1040-1046.<lb/> </bibl>
        <bibl><label>[160]</label> Seugnet, L.; Galvin, J.E.; Suzuki, Y.; Gottschalk, L.; Shaw, P.J.<lb/> Persistent short-term memory defects following sleep deprivation<lb/> in a drosophila model of Parkinson disease. Sleep, 2009, 32, 984-<lb/>992.<lb/> </bibl>
        <bibl><label>[161]</label> Wang, D.; Qian, L.; Xiong, H.; Liu, J.; Neckameyer, W.S.;<lb/> Oldham, S.; Xia, K.; Wang, J.; Bodmer, R.; Zhang, Z. Antioxidants<lb/> protect PINK1-dependent dopaminergic neurons in Drosophila.<lb/> Proc. Natl. Acad. Sci. USA, 2006, 103, 13520-13525.<lb/> </bibl>
        <bibl><label>[162]</label> Yang, Y.; Ouyang, Y.; Yang, L.; Beal, M.F.; McQuibban, A.;<lb/> Vogel, H.; Lu, B. Pink1 regulates mitochondrial dynamics through<lb/> interaction with the fission/fusion machinery. Proc. Natl. Acad. Sci.<lb/> USA, 2008, 105, 7070-7075.<lb/> </bibl>
        <bibl><label>[163]</label> Wang, C.; Lu, R.; Ouyang, X.; Ho, M.W.; Chia, W.; Yu, F.; Lim,<lb/> K.L. Drosophila overexpressing parkin R275W mutant exhibits<lb/> dopaminergic<lb/> neuron<lb/> degeneration<lb/> and<lb/> mitochondrial<lb/> abnormalities. J. Neurosci., 2007, 27, 8563-8570.<lb/> </bibl>
        <bibl><label>[164]</label> Sang, T.K.; Chang, H.Y.; Lawless, G.M.; Ratnaparkhi, A.; Mee, L.;<lb/> Ackerson, L.C.; Maidment, N.T.; Krantz, D.E.; Jackson, G.R. A<lb/> Drosophila model of mutant human parkin-induced toxicity<lb/> demonstrates selective loss of dopaminergic neurons and<lb/> dependence on cellular dopamine. J. Neurosci., 2007, 27, 981-992.<lb/> </bibl>
        <bibl><label>[165]</label> Lee, S.B.; Kim, W.; Lee, S.; Chung, J. Loss of LRRK2/PARK8<lb/> induces degeneration of dopaminergic neurons in Drosophila.<lb/> Biochem. Biophys. Res. Commun., 2007, 358, 534-539.<lb/> </bibl>
        <bibl><label>[166]</label> Liu, Z.; Wang, X.; Yu, Y.; Li, X.; Wang, T.; Jiang, H.; Ren, Q.;<lb/> Jiao, Y.; Sawa, A.; Moran, T.; Ross, C.A.; Montell, C.; Smith,<lb/> W.W. A Drosophila model for LRRK2-linked parkinsonism. Proc.<lb/> Natl. Acad. Sci. USA, 2008, 105, 2693-2698.<lb/> </bibl>
        <bibl><label>[167]</label> Imai, Y.; Gehrke, S.; Wang, H.Q.; Takahashi, R.; Hasegawa, K.;<lb/> Oota, E.; Lu, B. Phosphorylation of 4E-BP by LRRK2 affects the<lb/> maintenance of dopaminergic neurons in Drosophila. EMBO J.,<lb/> 2008, 27, 2432-2443.<lb/> </bibl>
        <bibl><label>[168]</label> Ng, C.H.; Mok, S.Z.; Koh, C.; Ouyang, X.; Fivaz, M.L.; Tan, E.K.;<lb/> Dawson, V.L.; Dawson, T.M.; Yu, F.; Lim, K.L. Parkin protects<lb/> against<lb/> LRRK2<lb/> G2019S<lb/> mutant-induced<lb/> dopaminergic<lb/> neurodegeneration in Drosophila. J. Neurosci., 2009, 29, 11257-<lb/>11262.<lb/> </bibl>
        <bibl><label>[169]</label> Venderova, K.; Kabbach, G.; Abdel-Messih, E.; Zhang, Y.; Parks,<lb/> R.J.; Imai, Y.; Gehrke, S.; Ngsee, J.; Lavoie, M.J.; Slack, R.S.;<lb/> Rao, Y.; Zhang, Z.; Lu, B.; Haque, M.E.; Park, D.S. Leucine-Rich<lb/> Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a<lb/> Drosophila melanogaster model of Parkinson&apos;s disease. Hum. Mol.<lb/> Genet., 2009, 18, 4390-4404.<lb/> </bibl>
        <bibl><label>[170]</label> Clark, I.E.; Dodson, M.W.; Jiang, C.; Cao, J.H.; Huh, J.R.; Seol,<lb/> J.H.; Yoo, S.J.; Hay, B.A.; Guo, M. Drosophila pink1 is required<lb/> for mitochondrial function and interacts genetically with parkin.<lb/> Nature, 2006, 441, 1162-116.<lb/> </bibl>
        <bibl><label>[171]</label> Park, J.; Lee, S.B.; Lee, S.; Kim, Y.; Song, S.; Kim, S.; Bae, E.;<lb/> Kim, J.; Shong, M.; Kim, J.M.; Chung, J. Mitochondrial<lb/> dysfunction in Drosophila PINK1 mutants is complemented by<lb/> parkin. Nature, 2006, 441, 1157-1161.<lb/> </bibl>
        <bibl><label>[172]</label> Yang, Y.; Gehrke, S.; Imai, Y.; Huang, Z.; Ouyang, Y.; Wang,<lb/> J.W.; Yang, L.; Beal, M.F.; Vogel, H.; Lu, B. Mitochondrial<lb/> pathology and muscle and dopaminergic neuron degeneration<lb/> caused by inactivation of Drosophila Pink1 is rescued by Parkin.<lb/> Proc. Natl. Acad. Sci. USA, 2006, 103, 10793-10798.<lb/> </bibl>
        <bibl><label>[173]</label> Tain, L.S.; Mortiboys, H.; Tao, R.N.; Ziviani, E.; Bandmann, O.;<lb/> Whitworth, A.J. Rapamycin activation of 4E-BP prevents<lb/> parkinsonian dopaminergic neuron loss. Nat. Neurosci., 2009, 12,<lb/> 1129-1135.<lb/> </bibl>
        <bibl><label>[174]</label> Greene, J.C.; Whitworth, A.J.; Kuo, I.; Andrews, L.A.; Feany,<lb/> M.B.; Pallanck, L.J. Mitochondrial pathology and apoptotic muscle<lb/> degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci.<lb/> USA, 2003, 100, 4078-4083.<lb/> </bibl>
        <bibl><label>[175]</label> Greene, J.C.; Whitworth, A.J.; Andrews, L.A.; Parker, T.J.;<lb/> Pallanck, L.J. Genetic and genomic studies of Drosophila parkin<lb/> mutants implicate oxidative stress and innate immune responses in<lb/> pathogenesis. Hum. Mol. Genet., 2005, 14, 799-811.<lb/> </bibl>
        <bibl><label>[176]</label> Cha, G.H.; Kim, S.; Park, J.; Lee, E.; Kim, M.; Lee, S.B.; Kim,<lb/> J.M.; Chung, J.; Cho, K.S. Parkin negatively regulates JNK<lb/> pathway in the dopaminergic neurons of Drosophila. Proc. Natl.<lb/> Acad. Sci. USA, 2005, 102, 10345-10350.<lb/> </bibl>
        <bibl><label>[177]</label> Meulener, M.; Whitworth, A.J.; Armstrong-Gold, C.E.; Rizzu, P.;<lb/> Heutink, P.; Wes, P.D.; Pallanck, L.J.; Bonini, N.M. Drosophila<lb/> DJ-1 mutants are selectively sensitive to environmental toxins<lb/> associated with Parkinson&apos;s disease. Curr. Biol., 2005, 15, 1572-<lb/>1577.<lb/> </bibl>
        <bibl><label>[178]</label> Park, J.; Kim, S.Y.; Cha, G.H.; Lee, S.B.; Kim, S.; Chung, J.<lb/> Drosophila DJ-1 mutants show oxidative stress-sensitive<lb/> locomotive dysfunction. Gene, 2005, 361, 133-139.<lb/> </bibl>
        <bibl><label>[179]</label> Menzies, F.M.; Yenisetti, S.C.; Min, K.T. Roles of Drosophila DJ-<lb/>1 in survival of dopaminergic neurons and oxidative stress. Curr.<lb/> Biol., 2005, 15, 1578-1582.<lb/> </bibl>
        <bibl><label>[180]</label> Yang, Y.; Gehrke, S.; Haque, M.E.; Imai, Y.; Kosek, J.; Yang, L.;<lb/> Beal, M.F.; Nishimura, I.; Wakamatsu, K.; Ito, S.; Takahashi, R.;<lb/> Lu, B. Inactivation of Drosophila DJ-1 leads to impairments of<lb/> oxidative stress response and phosphatidylinositol 3-kinase/Akt<lb/> signaling. Proc. Natl. Acad. Sci. USA, 2005, 102, 13670-13675.<lb/> </bibl>
        <bibl><label>[181]</label> Meulener, M.C.; Xu, K.; Thomson, L.; Ischiropoulos, H.; Bonini,<lb/> N.M. Mutational analysis of DJ-1 in Drosophila implicates<lb/> functional inactivation by oxidative damage and aging. Proc. Natl.<lb/> Acad. Sci. USA, 2006, 103, 12517-12522.<lb/> </bibl>
        <bibl><label>[182]</label> Lavara-Culebras, E.; Paricio, N. Drosophila DJ-1 mutants are<lb/> sensitive to oxidative stress and show reduced lifespan and motor<lb/> deficits. Gene, 2007, 400, 158-165.<lb/> </bibl>
        <bibl><label>[183]</label> Wang, D.; Tang, B.; Zhao, G.; Pan, Q.; Xia, K.; Bodmer, R.;<lb/> Zhang, Z. Dispensable role of Drosophila ortholog of LRRK2<lb/> kinase activity in survival of dopaminergic neurons. Mol.<lb/> Neurodegener., 2008, 8, 3:3.<lb/> </bibl>
        <bibl><label>[184]</label> Whitworth, A.J.; Lee, J.R.; Ho, V.M.; Flick, R.; Chowdhury, R.;<lb/> McQuibban, G.A. Rhomboid-7 and HtrA2/Omi act in a common<lb/> pathway with the Parkinson&apos;s disease factors Pink1 and Parkin. Dis.<lb/> Model Mech., 2008, 1, 168-174.<lb/> </bibl>
        <bibl><label>[185]</label> Yun, J.; Cao, J.H.; Dodson, M.W.; Clark, I.E.; Kapahi, P.;<lb/> Chowdhury, R.B.; Guo, M. Loss-of-function analysis suggests that<lb/> Omi/HtrA2 is not an essential component of the PINK1/PARKIN<lb/> pathway in vivo. J. Neurosci., 2008, 28, 14500-10.<lb/> </bibl>
        <bibl><label>[186]</label> Tain, L.S.; Chowdhury, R.B.; Tao, R.N.; Plun-Favreau, H.; Moisoi,<lb/> N.; Martins, L.M.; Downward, J.; Whitworth, A.J.; Tapon, N.<lb/> Drosophila HtrA2 is dispensable for apoptosis but acts downstream<lb/> of PINK1 independently from Parkin. Cell Death Differ., 2009, 16,<lb/> 1118-1125.<lb/> </bibl>
        <bibl><label>[187]</label> Pesah, Y.; Burgess, H.; Middlebrooks, B.; Ronningen, K.; Prosser,<lb/> J.; Tirunagaru, V.; Zysk, J.; Mardon, G. Whole-mount analysis<lb/> reveals normal numbers of dopaminergic neurons following<lb/> misexpression of alpha-Synuclein in Drosophila. Genesis, 2005,<lb/> 41, 154-159.<lb/> </bibl>
        <bibl><label>[188]</label> Coulom, H.; Birman, S. Chronic exposure to rotenone models<lb/> sporadic Parkinson&apos;s disease in Drosophila melanogaster. J.<lb/> Neurosci., 2004, 24, 10993-8.<lb/> </bibl>
        <bibl><label>[189]</label> Chaudhuri, A.; Bowling, K.; Funderburk, C.; Lawal, H.; Inamdar,<lb/> A.; Wang, Z.; O&apos;Donnell, J.M. Interaction of genetic and<lb/> environmental factors in a Drosophila parkinsonism model. J.<lb/> Neurosci., 2007, 27, 2457-67.<lb/> </bibl>
        <bibl><label>[190]</label> Chen, L.; Feany, M.B. Alpha-synuclein phosphorylation controls<lb/> neurotoxicity and inclusion formation in a Drosophila model of<lb/> Parkinson disease. Nat. Neurosci., 2005, 8, 657-663.<lb/> </bibl>
        <bibl><label>[191]</label> Sidhu, A.; Wersinger, C.; Vernier, P. Does alpha-synuclein<lb/> modulate dopaminergic synaptic content and tone at the synapse?<lb/> FASEB J., 2004, 18, 637-47.<lb/> </bibl>
        <bibl><label>[192]</label> Karpinar, D.P.; Balija, M.B.; Kügler, S.; Opazo, F.; Rezaei-Ghaleh,<lb/> N.; Wender, N.; Kim, H.Y.; Taschenberger, G.; Falkenburger,<lb/> B.H.; Heise, H.; Kumar, A.; Riedel, D.; Fichtner, L.; Voigt, A.;<lb/> Braus, G.H.; Giller, K.; Becker, S.; Herzig, A.; Baldus, M.; Jäckle,<lb/> H.; Eimer, S.; Schulz, J.B.; Griesinger, C.; Zweckstetter, M. Pre-<lb/>fibrillar alpha-synuclein variants with impaired beta-structure<lb/> increase neurotoxicity in Parkinson&apos;s disease models. EMBO J.,<lb/> 2009, 28, 3256-3268.<lb/> </bibl>
        <bibl><label>[193]</label> Chen, L.; Periquet, M.; Wang, X.; Negro, A.; McLean, P.J.;<lb/> Hyman, B.T.; Feany, M.B. Tyrosine and serine phosphorylation of<lb/> alpha-synuclein have opposing effects on neurotoxicity and soluble<lb/> oligomer formation. J. Clin. Invest., 2009, 119, 3257-3265.<lb/> </bibl>
        <bibl><label>[194]</label> Dufty, B.M.; Warner, L.R.; Hou, S.T.; Jiang, S.X.; Gomez-Isla, T.;<lb/> Leenhouts, K.M.; Oxford, J.T.; Feany, M.B.; Masliah, E.; Rohn,<lb/> T.T. Calpain-cleavage of alpha-synuclein: connecting proteolytic<lb/> processing to disease-linked aggregation. Am. J. Pathol., 2007,<lb/> 170, 1725-1738.<lb/> </bibl>
        <bibl><label>[195]</label> Kontopoulos, E.; Parvin, J.D.; Feany, M.B. Alpha-synuclein acts in<lb/> the nucleus to inhibit histone acetylation and promote<lb/> neurotoxicity. Hum. Mol. Genet., 2006, 15, 3012-3023.<lb/> </bibl>
        <bibl><label>[196]</label> Jia, H.; Li, X.; Gao, H.; Feng, Z.; Li, X.; Zhao, L.; Jia, X.; Zhang,<lb/> H.; Liu, J. High doses of nicotinamide prevent oxidative<lb/> mitochondrial dysfunction in a cellular model and improve motor<lb/> deficit in a Drosophila model of Parkinson&apos;s disease. J. Neurosci.<lb/> Res., 2008, 86, 2083-2090.<lb/> </bibl>
        <bibl><label>[197]</label> Wassef, R.; Haenold, R.; Hansel, A.; Brot, N.; Heinemann, S.H.;<lb/> Hoshi, T. Methionine sulfoxide reductase A and a dietary<lb/> supplement<lb/> S-methyl-L-cysteine<lb/> prevent<lb/> Parkinson&apos;s-like<lb/> symptoms. J. Neurosci., 2007, 27, 12808-12816.<lb/> </bibl>
        <bibl><label>[198]</label> Trinh, K.; Moore, K.; Wes, P.D.; Muchowski, P.J.; Dey, J.;<lb/> Andrews, L.; Pallanck, L.J. Induction of the phase II detoxification<lb/> pathway suppresses neuron loss in Drosophila models of<lb/> Parkinson&apos;s disease. J. Neurosci., 2008, 28, 465-472.<lb/> </bibl>
        <bibl><label>[199]</label> Umeda-Kameyama, Y.; Tsuda, M.; Ohkura, C.; Matsuo, T.;<lb/> Namba, Y.; Ohuchi, Y.; Aigaki, T. Thioredoxin suppresses Parkin-<lb/>associated endothelin receptor-like receptor-induced neurotoxicity<lb/> and extends longevity in Drosophila. J. Biol. Chem., 2007, 282,<lb/> 11180-11187.<lb/> </bibl>
        <bibl><label>[200]</label> van der Brug, M.P.; Blackinton, J.; Chandran, J.; Hao, L.Y.; Lal,<lb/> A.; Mazan-Mamczarz, K.; Martindale, J.; Xie, C.; Ahmad, R.;<lb/> Thomas, K.J.; Beilina, A.; Gibbs, J.R.; Ding, J.; Myers, A.J.; Zhan,<lb/> M.; Cai, H.; Bonini, N.M.; Gorospe, M.; Cookson, M.R. RNA<lb/> binding activity of the recessive parkinsonism protein DJ-1<lb/> supports involvement in multiple cellular pathways. Proc. Natl.<lb/> Acad. Sci. USA, 2008, 105, 10244-10249.<lb/> </bibl>
        <bibl><label>[201]</label> Kim, Y.; Park, J.; Kim, S.; Song, S.; Kwon, S.K.; Lee, S.H.;<lb/> Kitada, T.; Kim, J.M.; Chung, J. PINK1 controls mitochondrial<lb/> localization of Parkin through direct phosphorylation. Biochem.<lb/> Biophys. Res. Commun., 2008, 377, 975-980.<lb/> </bibl>
        <bibl><label>[202]</label> Wallace, D.C. A mitochondrial paradigm of metabolic and<lb/> degenerative diseases, aging, and cancer: a dawn for evolutionary<lb/> medicine. Annu. Rev. Genet., 2005, 39, 359-407.<lb/> </bibl>
        <bibl><label>[203]</label> Krishnan, K.J.; Greaves, L.C.; Reeve, A.K.; Turnbull, D.M.<lb/> Mitochondrial DNA mutations and aging. Ann. N. Y. Acad. Sci.,<lb/> 2007, 1100, 227-240.<lb/> </bibl>
        <bibl><label>[204]</label> Mattson, M.P.; Gleichmann, M.; Cheng, A. Mitochondria in<lb/> neuroplasticity and neurological disorders. Neuron, 2008, 60, 748-<lb/>766.<lb/> </bibl>
        <bibl><label>[205]</label> Poole, A.C.; Thomas, R.E.; Andrews, L.A.; McBride, H.M.;<lb/> Whitworth, A.J.; Pallanck, L.J. The PINK1/Parkin pathway<lb/> regulates mitochondrial morphology. Proc. Natl. Acad. Sci. USA,<lb/> 2008, 105, 1638-1643.<lb/> </bibl>
        <bibl><label>[206]</label> Deng, H.; Dodson, M.W.; Huang, H.; Guo, M. The Parkinson&apos;s<lb/> disease genes pink1 and parkin promote mitochondrial fission<lb/> and/or inhibit fusion in Drosophila. Proc. Natl. Acad. Sci. USA,<lb/> 2008, 105, 14503-14508.<lb/> </bibl>
        <bibl><label>[207]</label> Lutz, A.K.; Exner, N.; Fett, M.E.; Schlehe, J.S.; Kloos, K.;<lb/> Lämmermann, K.; Brunner, B.; Kurz-Drexler, A.; Vogel, F.;<lb/> Reichert, A.S.; Bouman, L.; Vogt-Weisenhorn, D.; Wurst, W.;<lb/> Tatzelt, J.; Haass, C.; Winklhofer, K.F. Loss of parkin or PINK1<lb/> function increases Drp1-dependent mitochondrial fragmentation. J.<lb/> Biol. Chem., 2009, 284, 22938-22951.<lb/> </bibl>
        <bibl><label>[208]</label> Orr, H.T.; Zoghbi, H.Y. Trinucleotide repeat disorders. Annu. Rev.<lb/> Neurosci., 2007, 30, 575-621.<lb/> </bibl>
        <bibl><label>[209]</label> Yamada, M.; Sato, T.; Tsuji, S.; Takahashi, H. CAG repeat<lb/> disorder models and human neuropathology: similarities and<lb/> differences. Acta Neuropathol., 2008, 115, 71-86.<lb/> </bibl>
        <bibl><label>[210]</label> Hands, S.; Sinadinos, C.; Wyttenbach, A. Polyglutamine gene<lb/> function and dysfunction in the ageing brain. Biochim. Biophys.<lb/> Acta., 2008, 1779, 507-521.<lb/> </bibl>
        <bibl><label>[211]</label> Perutz, M.F. Glutamine repeats and neurodegenerative diseases:<lb/> molecular aspects. Trends Biochem. Sci., 1999, 24, 58-63.<lb/> </bibl>
        <bibl><label>[212]</label> Gusella, J.F.; MacDonald, M.E. Molecular genetics: unmasking<lb/> polyglutamine triggers in neurodegenerative disease. Nat. Rev.<lb/> Neurosci., 2000, 1, 109-15.<lb/> </bibl>
        <bibl><label>[213]</label> Bettencourt, B.R.; Hogan, C.C.; Nimali, M. Polyglutamine<lb/> expansion in Drosophila: thermal stress and Hsp70 as selective<lb/> agents. J. Biosci., 2007, 32, 537-547.<lb/> </bibl>
        <bibl><label>[214]</label> Marsh, J.L.; Walker, H.; Theisen, H.; Zhu, Y.Z.; Fielder, T.;<lb/> Purcell, J.; Thompson, L.M. Expanded polyglutamine peptides<lb/> alone are intrinsically cytotoxic and cause neurodegeneration in<lb/> Drosophila. Hum. Mol. Genet., 2000, 9, 13-25.<lb/> </bibl>
        <bibl><label>[215]</label> Slepko, N.; Bhattacharyya, A.M.; Jackson, G.R.; Steffan, J.S.;<lb/> Marsh, J.L.; Thompson, L.M.; Wetzel, R. Normal-repeat-length<lb/> polyglutamine peptides accelerate aggregation nucleation and<lb/> cytotoxicity of expanded polyglutamine proteins. Proc. Natl. Acad.<lb/> Sci. USA, 2006, 103, 14367-14372.<lb/> </bibl>
        <bibl><label>[216]</label> Li, L.B.; Xu, K.; Bonini, N.M. Suppression of polyglutamine<lb/> toxicity by the yeast Sup35 prion domain in Drosophila. J. Biol.<lb/> Chem., 2007, 282, 37694-37701.<lb/> </bibl>
        <bibl><label>[217]</label> Romero, E.; Cha, G.H.; Verstreken, P.; Ly, C.V.; Hughes, R.E.;<lb/> Bellen, H.J.; Botas, J. Suppression of neurodegeneration and<lb/> increased neurotransmission caused by expanded full-length<lb/> huntingtin accumulating in the cytoplasm. Neuron, 2008, 57, 27-<lb/>40.<lb/> </bibl>
        <bibl><label>[218]</label> Zhang, S.; Feany, M.B.; Saraswati, S.; Littleton, J.T.; Perrimon, N.<lb/> Inactivation of Drosophila Huntingtin affects long-term adult<lb/> functioning and the pathogenesis of a Huntington&apos;s disease model.<lb/> Dis. Model Mech., 2009, 2, 247-266.<lb/> </bibl>
        <bibl><label>[219]</label> Al-Ramahi, I.; Pérez, A.M.; Lim, J.; Zhang, M.; Sorensen, R.; de<lb/> Haro, M.; Branco, J.; Pulst, S.M.; Zoghbi, H.Y.; Botas, J. dAtaxin-<lb/>2 mediates expanded Ataxin-1-induced neurodegeneration in a<lb/> Drosophila model of SCA1. PLoS Genet., 2007, 3, e234.<lb/> </bibl>
        <bibl><label>[220]</label> Lessing, D.; Bonini, N.M. Polyglutamine genes interact to<lb/> modulate the severity and progression of neurodegeneration in<lb/> Drosophila. PLoS Biol., 2008, 6, e29.<lb/> </bibl>
        <bibl><label>[221]</label> Fernandez-Funez, P.; Nino-Rosales, M.L.; de Gouyon, B.; She,<lb/> W.C.; Luchak, J.M.; Martinez, P.; Turiegano, E.; Benito, J.;<lb/> Capovilla, M.; Skinner, P.J.; McCall, A.; Canal, I.; Orr, H.T.;<lb/> Zoghbi, H.Y.; Botas, J. Identification of genes that modify ataxin-<lb/>1-induced neurodegeneration. Nature, 2000, 408, 101-106.<lb/> </bibl>
        <bibl><label>[222]</label> Kazemi-Esfarjani, P.; Benzer, S. Genetic suppression of<lb/> polyglutamine toxicity in Drosophila. Science, 2000, 287, 1837-<lb/>1840.<lb/> </bibl>
        <bibl><label>[223]</label> Agrawal, N.; Pallos, J.; Slepko, N.; Apostol, B.L.; Bodai, L.;<lb/> Chang, L.W.; Chiang, A.S.; Thompson, L.M.; Marsh, J.L.<lb/> Identification of combinatorial drug regimens for treatment of<lb/> Huntington&apos;s disease using Drosophila. Proc. Natl. Acad. Sci. USA,<lb/> 2005, 102, 3777-3781.<lb/> </bibl>
        <bibl><label>[224]</label> Ehrnhoefer, D.E.; Duennwald, M.; Markovic, P.; Wacker, J.L.;<lb/> Engemann, S.; Roark, M.; Legleiter, J.; Marsh, J.L.; Thompson,<lb/> L.M.; Lindquist, S.; Muchowski, P.J.; Wanker, E.E. Green tea (-)-<lb/>epigallocatechin-gallate modulates early events in huntingtin<lb/> misfolding and reduces toxicity in Huntington&apos;s disease models.<lb/> Hum. Mol. Genet., 2006, 15, 2743-2751.<lb/> </bibl>
        <bibl><label>[225]</label> Desai, U.A.; Pallos, J.; Ma, A.A.; Stockwell, B.R.; Thompson,<lb/> L.M.; Marsh, J.L.; Diamond, M.I. Biologically active molecules<lb/> that reduce polyglutamine aggregation and toxicity. Hum. Mol.<lb/> Genet., 2006, 15, 2114-2124.<lb/> </bibl>
        <bibl><label>[226]</label> Kaltenbach, L.S.; Romero, E.; Becklin, R.R.; Chettier, R.; Bell, R.;<lb/> Phansalkar, A.; Strand, A.; Torcassi, C.; Savage, J.; Hurlburt, A.;<lb/> Cha, G.H.; Ukani, L.; Chepanoske, C.L.; Zhen, Y.; Sahasrabudhe,<lb/> S.; Olson, J.; Kurschner, C.; Ellerby, L.M.; Peltier, J.M.; Botas, J.;<lb/> Hughes, R.E. Huntingtin interacting proteins are genetic modifiers<lb/> of neurodegeneration. PLoS Genet., 2007, 3, e82.<lb/> </bibl>
        <bibl><label>[227]</label> Bilen, J.; Bonini, N.M. Genome-wide screen for modifiers of<lb/> ataxin-3 neurodegeneration in Drosophila. PLoS Genet., 2007, 3,<lb/> 1950-1964.<lb/> </bibl>
        <bibl><label>[228]</label> Latouche, M.; Lasbleiz, C.; Martin, E.; Monnier, V.; Debeir, T.;<lb/> Mouatt-Prigent, A.; Muriel, M.P.; Morel, L.; Ruberg, M.; Brice, A.;<lb/> Stevanin, G.; Tricoire, H. A conditional pan-neuronal Drosophila<lb/> model of spinocerebellar ataxia 7 with a reversible adult phenotype<lb/> suitable for identifying modifier genes. J. Neurosci., 2007, 27,<lb/> 2483-2492.<lb/> </bibl>
        <bibl><label>[229]</label> Li, L.B.; Yu, Z.; Teng, X.; Bonini, N.M. RNA toxicity is a<lb/> component of ataxin-3 degeneration in Drosophila. Nature, 2008,<lb/> 453, 1107-1111.<lb/> </bibl>
        <bibl><label>[230]</label> Bilen, J.; Liu, N.; Burnett, B.G.; Pittman, R.N.; Bonini, N.M.<lb/> MicroRNA<lb/> pathways<lb/> modulate<lb/> polyglutamine-induced<lb/> neurodegeneration. Mol. Cell, 2006, 24, 157-63.<lb/> </bibl>
        <bibl><label>[231]</label> Sang, T.K.; Li, C.; Liu, W.; Rodriguez, A.; Abrams, J.M.;<lb/> Zipursky, S.L.; Jackson, G.R. Inactivation of Drosophila Apaf-1<lb/> related killer suppresses formation of polyglutamine aggregates and<lb/> blocks polyglutamine pathogenesis. Hum. Mol. Genet. 2005, 14,<lb/> 357-372.<lb/> </bibl>
        <bibl><label>[232]</label> Suzuki, E.; Zhao, Y.; Ito, S.; Sawatsubashi, S.; Murata, T.;<lb/> Furutani, T.; Shirode, Y.; Yamagata, K.; Tanabe, M.; Kimura, S.;<lb/> Ueda, T.; Fujiyama, S.; Lim, J.; Matsukawa, H.; Kouzmenko, A.P.;<lb/> Aigaki, T.; Tabata, T.; Takeyama, K.; Kato, S. Aberrant E2F<lb/> activation by polyglutamine expansion of androgen receptor in<lb/> SBMA neurotoxicity. Proc. Natl. Acad. Sci. USA, 2009, 106, 3818-<lb/>3822.<lb/> </bibl>
        <bibl><label>[233]</label> Chan, H.Y.; Warrick, J.M.; Andriola, I.; Merry, D.; Bonini, N.M.<lb/> Genetic modulation of polyglutamine toxicity by protein<lb/> conjugation pathways in Drosophila. Hum. Mol. Genet., 2002, 11,<lb/> 2895-2904.<lb/> </bibl>
        <bibl><label>[234]</label> Steffan, J.S.; Agrawal, N.; Pallos, J.; Rockabrand, E.; Trotman,<lb/> L.C.; Slepko, N.; Illes, K.; Lukacsovich, T.; Zhu, Y.Z.; Cattaneo,<lb/> E.; Pandolfi, P.P.; Thompson, L.M.; Marsh, J.L. SUMO<lb/> modification of Huntingtin and Huntington&apos;s disease pathology.<lb/> Science, 2004, 304, 100-104.<lb/> </bibl>
        <bibl><label>[235]</label> Chen, H.K.; Fernandez-Funez, P.; Acevedo, S.F.; Lam, Y.C.;<lb/> Kaytor, M.D.; Fernandez, M.H.; Aitken, A.; Skoulakis, E.M.; Orr,<lb/> H.T.; Botas, J.; Zoghbi, H.Y. Interaction of Akt-phosphorylated<lb/> ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar<lb/> ataxia type 1. Cell, 2003, 113, 457-468.<lb/> </bibl>
        <bibl><label>[236]</label> Sarkar, S.; Krishna, G.; Imarisio, S.; Saiki, S.; O&apos;Kane, C.J.;<lb/> Rubinsztein, D.C. A rational mechanism for combination treatment<lb/> of Huntington&apos;s disease using lithium and rapamycin. Hum. Mol.<lb/> Genet., 2008, 17, 170-178.<lb/> </bibl>
        <bibl><label>[237]</label> Steffan, J.S.; Bodai, L.; Pallos, J.; Poelman, M.; McCampbell, A.;<lb/> Apostol, B.L.; Kazantsev, A.; Schmidt, E.; Zhu, Y.Z.; Greenwald,<lb/> M.; Kurokawa, R.; Housman, D.E.; Jackson, G.R.; Marsh, J.L.;<lb/> Thompson, L.M. Histone deacetylase inhibitors arrest<lb/> polyglutamine-dependent neurodegeneration in Drosophila. Nature,<lb/> 2001, 413, 739-743.<lb/> </bibl>
        <bibl><label>[238]</label> Pandey, U.B.; Nie, Z.; Batlevi, Y.; McCray, B.A.; Ritson, G.P.;<lb/> Nedelsky, N.B.; Schwartz, S.L.; DiProspero, N.A.; Knight, M.A.;<lb/> Schuldiner, O.; Padmanabhan, R.; Hild, M.; Berry, D.L.; Garza, D.;<lb/> Hubbert, C.C.; Yao, T.P.; Baehrecke, E.H.; Taylor, J.P. HDAC6<lb/> rescues neurodegeneration and provides an essential link between<lb/> autophagy and the UPS. Nature, 2007, 447, 859-863.<lb/> </bibl>
        <bibl><label>[239]</label> Pallos, J.; Bodai, L.; Lukacsovich, T.; Purcell, J.M.; Steffan, J.S.;<lb/> Thompson, L.M.; Marsh, J.L. Inhibition of specific HDACs and<lb/> sirtuins suppresses pathogenesis in a Drosophila model of<lb/> Huntington&apos;s disease. Hum. Mol. Genet., 2008, 17, 3767-3775.<lb/> </bibl>
        <bibl><label>[240]</label> Pan, L.; Zhang, Y.Q.; Woodruff, E.; Broadie, K. The Drosophila<lb/> fragile X gene negatively regulates neuronal elaboration and<lb/> synaptic differentiation. Curr. Biol., 2004, 14, 1863-1870.<lb/> </bibl>
        <bibl><label>[241]</label> Lee, A.; Li, W.; Xu, K.; Bogert, B.A.; Su, K.; Gao, F.B. Control of<lb/> dendritic development by the Drosophila fragile X-related gene<lb/> involves the small GTPase Rac1. Development, 2003, 130, 5543-<lb/>5552.<lb/> </bibl>
        <bibl><label>[242]</label> Xu, K.; Bogert, B.A.; Li, W.; Su, K.; Lee, A.; Gao, F.B. The fragile<lb/> X-related gene affects the crawling behavior of Drosophila larvae<lb/> by regulating the mRNA level of the DEG/ENaC protein<lb/> pickpocket1. Curr. Biol., 2004, 14, 1025-1034.<lb/> </bibl>
        <bibl><label>[243]</label> Cziko, A.M.; McCann, C.T.; Howlett, I.C.; Barbee, S.A.; Duncan,<lb/> R.P.; Luedemann, R.; Zarnescu, D.; Zinsmaier, K.E.; Parker, R.R.;<lb/> Ramaswami, M. Genetic modifiers of dFMR1 encode RNA granule<lb/> components in Drosophila. Genetics, 2009, 182, 1051-1060.<lb/> </bibl>
        <bibl><label>[244]</label> Gatto, C.L.; Broadie, K. Temporal requirements of the fragile X<lb/> mental retardation protein in the regulation of synaptic structure.<lb/> Development, 2008, 135, 2637-2648.<lb/> </bibl>
        <bibl><label>[245]</label> Cheever, A.; Ceman, S. Translation regulation of mRNAs by the<lb/> fragile X family of proteins through the microRNA pathway. RNA<lb/> Biol., 2009, 6, 175-178.<lb/> </bibl>
        <bibl><label>[246]</label> Anderson, P.R.; Kirby, K.; Hilliker, A.J.; Phillips, J.P. RNAi-<lb/>mediated suppression of the mitochondrial iron chaperone, frataxin,<lb/> in Drosophila. Hum. Mol. Genet., 2005, 14, 3397-405.<lb/> </bibl>
        <bibl><label>[247]</label> Anderson, P.R.; Kirby, K.; Orr, W.C.; Hilliker, A.J.; Phillips, J.P.<lb/> Hydrogen peroxide scavenging rescues frataxin deficiency in a<lb/> Drosophila model of Friedreich&apos;s ataxia. Proc. Natl. Acad. Sci.<lb/> USA, 2008, 105, 611-616.<lb/> </bibl>
        <bibl><label>[248]</label> Llorens, J.V.; Navarro, J.A.; Martínez-Sebastián, M.J.; Baylies,<lb/> M.K.; Schneuwly, S.; Botella, J.A.; Moltó, M.D. Causative role of<lb/> oxidative stress in a Drosophila model of Friedreich ataxia. FASEB<lb/> J., 2007, 21, 333-344.<lb/> </bibl>
        <bibl><label>[249]</label> Donaghy, M. Classification and clinical features of motor neurone<lb/> diseases and motor neuropathies in adults. J. Neurol., 1999, 246,<lb/> 331-333.<lb/> </bibl>
        <bibl><label>[250]</label> Monani, U.R. Spinal Muscular Atrophy: a deficiency in a<lb/> ubiquitous protein; a motor neuron-specific disease. Neuron, 2005,<lb/> 48, 885-896.<lb/> </bibl>
        <bibl><label>[251]</label> Pasinelli, P.; Brown, R.H. Molecular biology of amyotrophic<lb/> lateral sclerosis: insights from genetics. Nat. Rev. Neurosci., 2006,<lb/> 7, 710-723.<lb/> </bibl>
        <bibl><label>[252]</label> Forman, M.S.; Trojanowski, J.Q.; Lee, V.M. TDP-43: a novel<lb/> neurodegenerative proteinopathy. Curr. Opin. Neurobiol., 2007,<lb/> 17, 1-8.<lb/> </bibl>
        <bibl><label>[253]</label> Van Damme, P.; Robberecht, W. Recent advances in motor neuron<lb/> disease. Curr. Opin. Neurol., 2009, 22, 486-492.<lb/> </bibl>
        <bibl><label>[254]</label> Dion, P.A.; Daoud, H.; Rouleau, G.A. Genetics of motor neuron<lb/> disorders: new insights into pathogenic mechanisms. Nat. Rev.<lb/> Genet., 2009, 10, 769-782.<lb/> </bibl>
        <bibl><label>[255]</label> Burghes, A.H.; Beattie, C.E. Spinal muscular atrophy: why do low<lb/> levels of survival motor neuron protein make motor neurons sick?<lb/> Nat. Rev. Neurosci., 2009, 10, 597-609.<lb/> </bibl>
        <bibl><label>[256]</label> Rothstein, J.D. Current hypotheses for the underlying biology of<lb/> amyotrophic lateral sclerosis. Ann. Neurol., 2009, 65(Suppl 1), S3-<lb/>9.<lb/> </bibl>
        <bibl><label>[257]</label> Phillips, J.P.; Tainer, J.A.; Getzoff, E.D.; Boulianne, G.L.; Kirby,<lb/> K.; Hilliker, A.J. Subunit-destabilizing mutations in Drosophila<lb/> copper/zinc superoxide dismutase: neuropathology and a model of<lb/> dimer dysequilibrium. Proc. Natl. Acad. Sci. USA, 1995, 92, 8574-<lb/>8578.<lb/> </bibl>
        <bibl><label>[258]</label> Parkes, T.L.; Elia, A.J.; Dickinson, D.; Hilliker, A.J.; Phillips, J.P.;<lb/> Boulianne, G.L. Extension of Drosophila lifespan by<lb/> overexpression of human SOD1 in motorneurons. Nat. Genet.,<lb/> 1998, 19, 171-174.<lb/> </bibl>
        <bibl><label>[259]</label> Elia, A.J.; Parkes, T.L.; Kirby, K.; St. George-Hyslop, P.;<lb/> Boulianne, G.L.; Phillips, J.P.; Hilliker, A.J. Expression of human<lb/> FALS SOD in motorneurons of Drosophila. Free Radic. Biol.<lb/> Med., 1999, 26, 1332-1338.<lb/> </bibl>
        <bibl><label>[260]</label> Mockett, R.J.; Radyuk, S.N.; Benes, J.J.; Orr, W.C.; Sohal, R.S.<lb/> Phenotypic effects of familial amyotrophic lateral sclerosis mutant<lb/> Sod alleles in transgenic Drosophila. Proc. Natl. Acad. Sci. USA,<lb/> 2003, 100, 301-306.<lb/> </bibl>
        <bibl><label>[261]</label> Watson, M.R.; Lagow, R.D.; Xu, K.; Zhang, B.; Bonini, N.M. A<lb/> Drosophila model for amyotrophic lateral sclerosis reveals motor<lb/> neuron damage by human SOD1. J. Biol. Chem., 2008, 283, 24972-<lb/>24981.<lb/> </bibl>
        <bibl><label>[262]</label> Buratti, E.; Baralle, F.E. Multiple roles of TDP-43 in gene<lb/> expression, splicing regulation, and human disease. Front. Biosci.,<lb/> 2008, 13, 867-878.<lb/> </bibl>
        <bibl><label>[263]</label> Wang, I.F.; Wu, L.S.; Shen, C.K. TDP-43: an emerging new player<lb/> in neurodegenerative diseases. Trends Mol. Med., 2008, 14, 479-<lb/>485.<lb/> </bibl>
        <bibl><label>[264]</label> Neumann, M. Molecular Neuropathology of TDP-43<lb/> Proteinopathies. Int. J. Mol. Sci., 2009, 10, 232-246.<lb/> </bibl>
        <bibl><label>[265]</label> Feiguin, F.; Godena, V.K.; Romano, G.; D&apos;Ambrogio, A.; Klima,<lb/> R.; Baralle, F.E. Depletion of TDP-43 affects Drosophila<lb/> motoneurons terminal synapsis and locomotive behavior. FEBS<lb/> Lett., 2009, 583, 1586-1592.<lb/> </bibl>
        <bibl><label>[266]</label> Lu, Y.; Ferris, J.; Gao, F.B. Frontotemporal dementia and<lb/> amyotrophic lateral sclerosis-associated disease protein TDP-43<lb/> promotes dendritic branching. Mol. Brain, 2009, 2, 30.<lb/> </bibl>
        <bibl><label>[267]</label> Fiesel, F.C.; Voigt, A.; Weber, S.S.; Van den Haute, C.;<lb/> Waldenmaier, A.; Görner, K.; Walter, M.; Anderson, M.L.; Kern,<lb/> J.V.; Rasse, T.M.; Schmidt, T.; Springer, W.; Kirchner, R.; Bonin,<lb/> M.; Neumann, M.; Baekelandt, V.; Alunni-Fabbroni, M.; Schulz,<lb/> J.B.; Kahle, P.J. Knockdown of transactive response DNA-binding<lb/> protein (TDP-43) downregulates histone deacetylase 6. EMBO J.,<lb/> 2009, 29, 209-221.<lb/> </bibl>
        <bibl><label>[268]</label> Li, Y.; Ray, P.; Rao, E.J.; Shi, C.; Guo, W.; Chen, X.; Woodruff,<lb/> E.A.; Fushimi, K.; Wu, J.Y. A Drosophila model for TDP-43<lb/> proteinopathy. Proc. Natl. Acad. Sci. USA, 2010, [Epub ahead of<lb/> print].<lb/> </bibl>
        <bibl><label>[269]</label> Pennetta, G.; Hiesinger, P.R.; Fabian-Fine, R.; Meinertzhagen,<lb/> I.A.; Bellen, H.J. Drosophila VAP-33A directs bouton formation at<lb/> neuromuscular junctions in a dosage-dependent manner. Neuron,<lb/> 2002, 35, 291-306.<lb/> </bibl>
        <bibl><label>[270]</label> Ratnaparkhi, A.; Lawless, G.M.; Schweizer, F.E.; Golshani, P.;<lb/> Jackson, G.R. A Drosophila model of ALS: human ALS-associated<lb/> mutation in VAP33A suggests a dominant negative mechanism.<lb/> PLoS One, 2008, 3, e2334.<lb/> </bibl>
        <bibl><label>[271]</label> Chai, A.; Withers, J.; Koh, Y.H.; Parry, K.; Bao, H.; Zhang, B.;<lb/> Budnik, V.; Pennetta, G. hVAPB, the causative gene of a<lb/> heterogeneous group of motor neuron diseases in humans, is<lb/> functionally interchangeable with its Drosophila homologue<lb/> DVAP-33A at the neuromuscular junction. Hum. Mol. Genet.,<lb/> 2008, 17, 266-280.<lb/> </bibl>
        <bibl><label>[272]</label> Tsuda, H.; Han, S.M.; Yang, Y.; Tong, C.; Lin, Y.Q.; Mohan, K.;<lb/> Haueter, C.; Zoghbi, A.; Harati, Y.; Kwan, J.; Miller, M.A.; Bellen,<lb/> H.J. The amyotrophic lateral sclerosis 8 protein VAPB is cleaved,<lb/> secreted, and acts as a ligand for Eph receptors. Cell, 2008, 133,<lb/> 963-977.<lb/> </bibl>
        <bibl><label>[273]</label> Chan, Y.B.; Miguel-Aliaga, I.; Franks, C.; Thomas, N.; Trülzsch,<lb/> B.; Sattelle, D.B.; Davies, K.E.; van den Heuvel, M.<lb/> Neuromuscular defects in a Drosophila survival motor neuron gene<lb/> mutant. Hum. Mol. Genet., 2003, 12, 1367-1376.<lb/> </bibl>
        <bibl><label>[274]</label> Rajendra, T.K.; Gonsalvez, G.B.; Walker, M.P.; Shpargel, K.B.;<lb/> Salz, H.K.; Matera, A.G. A Drosophila melanogaster model of<lb/> spinal muscular atrophy reveals a function for SMN in striated<lb/> muscle. J. Cell Biol., 2007, 176, 831-841.<lb/> </bibl>
        <bibl><label>[275]</label> Chang, H.C.; Dimlich, D.N.; Yokokura, T.; Mukherjee, A.; Kankel,<lb/> M.W.; Sen, A.; Sridhar, V.; Fulga, T.A.; Hart, A.C.; Van Vactor,<lb/> D.; Artavanis-Tsakonas, S. Modeling spinal muscular atrophy in<lb/> Drosophila. PLoS One, 2008, 3, e3209.<lb/> </bibl>
        <bibl><label>[276]</label> Salinas, S.; Proukakis, C.; Crosby, A.; Warner, T.T. Hereditary<lb/> spastic paraplegia: clinical features and pathogenetic mechanisms.<lb/> Lancet Neurol., 2008, 7, 1127-1138.<lb/> </bibl>
        <bibl><label>[277]</label> Hazan, J.; Fonknechten, N.; Mavel, D.; Paternotte, C.; Samson, D.;<lb/> Artiguenave, F.; Davoine, C.S.; Cruaud, C.; Dürr, A.; Wincker, P.;<lb/> Brottier, P.; Cattolico, L.; Barbe, V.; Burgunder, J.M.;<lb/> Prud&apos;homme, J.F.; Brice, A.; Fontaine, B.; Heilig, B.; Weissenbach,<lb/> J. Spastin, a new AAA protein, is altered in the most frequent form<lb/> of autosomal dominant spastic paraplegia. Nat. Genet., 1999, 23,<lb/> 296-303.<lb/> </bibl>
        <bibl><label>[278]</label> Kammermeier, L.; Spring, J.; Stierwald, M.; Burgunder, J.M.;<lb/> Reichert, H. Identification of the Drosophila melanogaster<lb/> homolog of the human spastin gene. Dev. Genes Evol., 2003, 213,<lb/> 412-415.<lb/> </bibl>
        <bibl><label>[279]</label> Trotta, N.; Orso, G.; Rossetto, M.G.; Daga, A.; Broadie, K. The<lb/> hereditary spastic paraplegia gene, spastin, regulates microtubule<lb/> stability to modulate synaptic structure and function. Curr. Biol.,<lb/> 2004, 14, 1135-1147.<lb/> </bibl>
        <bibl><label>[280]</label> Sherwood, N.T.; Sun, Q.; Xue, M.; Zhang, B.; Zinn, K. Drosophila<lb/> spastin regulates synaptic microtubule networks and is required for<lb/> normal motor function. PLoS Biol., 2004, 2, e429.<lb/> </bibl>
        <bibl><label>[281]</label> Roll-Mecak, A.; Vale, R.D. The Drosophila homologue of the<lb/> hereditary spastic paraplegia protein, spastin, severs and<lb/> disassembles microtubules. Curr. Biol., 2005, 15, 650-655.<lb/> </bibl>
        <bibl><label>[282]</label> Orso, G.; Martinuzzi, A.; Rossetto, M.G.; Sartori, E.; Feany, M.;<lb/> Daga, A. Disease-related phenotypes in a Drosophila model of<lb/> hereditary spastic paraplegia are ameliorated by treatment with<lb/> vinblastine. J. Clin. Invest., 2005, 115, 3026-3034.<lb/> </bibl>
        <bibl><label>[283]</label> Wang, X.; O&apos;Kane, C.J. Hereditary spastic paraplegia genes in<lb/> Drosophila: dissecting their roles in axonal degeneration and<lb/> intracellular traffic. SEB Exp. Biol. Ser., 2008, 60, 161-182.<lb/> </bibl>
        <bibl><label>[284]</label> Orso, G.; Pendin, D.; Liu, S.; Tosetto, J.; Moss, T.J.; Faust, J.E.;<lb/> Micaroni, M.; Egorova, A.; Martinuzzi, A.; McNew, JA.; Daga, A.<lb/> Homotypic fusion of ER membranes requires the dynamin-like<lb/> GTPase atlastin. Nature, 2009, 460, 978-983.<lb/> </bibl>
        <bibl><label>[285]</label> Lee, M.; Paik, S.K.; Lee, M.J.; Kim, Y.J.; Kim, S.; Nahm, M.; Oh,<lb/> S.J.; Kim, H.M.; Yim, J.; Lee, C.J.; Bae, Y.C.; Lee, S. Drosophila<lb/> Atlastin regulates the stability of muscle microtubules and is<lb/> required for synapse development. Dev. Biol., 2009, 330, 250-262.<lb/> </bibl>
        <bibl><label>[286]</label> Wang, X.; Shaw, W.R.; Tsang, H.T.; Reid, E.; O&apos;Kane, C.J.<lb/> Drosophila spichthyin inhibits BMP signaling and regulates<lb/> synaptic growth and axonal microtubules. Nat. Neurosci., 2007, 10,<lb/> 177-185.<lb/> </bibl>
        <bibl><label>[287]</label> Tsang, H.T.; Edwards, T.L.; Wang, X.; Connell, J.W.; Davies, R.J.;<lb/> Durrington, H.J.; O&apos;Kane, C.J.; Luzio, J.P.; Reid, E. The hereditary<lb/> spastic paraplegia proteins NIPA1, spastin and spartin are<lb/> inhibitors of mammalian BMP signalling. Hum. Mol. Genet., 2009,<lb/> 18, 3805-3821.<lb/> </bibl>
        <bibl><label>[288]</label> Keshishian, H.; Kim, Y.S. Orchestrating development and function:<lb/> retrograde BMP signaling in the Drosophila nervous system.<lb/> Trends Neurosci., 2004, 27, 143-147.<lb/> </bibl>
        <bibl><label>[289]</label> Tsuchida, K. The role of myostatin and bone morphogenetic<lb/> proteins in muscular disorders. Expert Opin. Biol. Ther., 2006, 6,<lb/> 147-54.<lb/> </bibl>
        <bibl><label>[290]</label> Lansbury, P.T.; Lashuel, H.A. A century-old debate on protein<lb/> aggregation and neurodegeneration enters the clinic. Nature, 2006,<lb/> 443, 774-9.<lb/> </bibl>
        <bibl><label>[291]</label> Gunther, E.C.; Strittmatter, S.M. Beta-amyloid oligomers and<lb/> cellular prion protein in Alzheimer&apos;s disease. J. Mol. Med., 2010,<lb/> 88, 331-338.<lb/> </bibl>
        <bibl><label>[292]</label> Aguzzi, A.; Rajendran, L. The transcellular spread of cytosolic<lb/> amyloids, prions, and prionoids. Neuron, 2009, 64, 783-90.<lb/> </bibl>
        <bibl><label>[293]</label> Hardy, J. Expression of normal sequence pathogenic proteins for<lb/> neurodegenerative disease contributes to disease risk: &apos;permissive<lb/> templating&apos; as a general mechanism underlying neurodegeneration.<lb/> Biochem. Soc. Trans., 2005, 33, 578-81.<lb/> </bibl>
        <bibl><label>[294]</label> Alberti, S.; Halfmann, R.; King, O.; Kapila, A.; Lindquist, S. A<lb/> systematic survey identifies prions and illuminates sequence<lb/> features of prionogenic proteins. Cell, 2009, 137, 146-158.<lb/> </bibl>
        <bibl><label>[295]</label> Nordling, C.O. A new theory on cancer-inducing mechanism. Br. J.<lb/> Cancer, 1953, 7, 68-72.</bibl>
        </listBibl>
    </text>
</tei>

